<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Trials</journal-id>
<journal-id journal-id-type="iso-abbrev">Trials</journal-id>
<journal-title-group>
<journal-title>Trials</journal-title>
</journal-title-group>
<issn pub-type="epub">1745-6215</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30514364</article-id>
<article-id pub-id-type="pmc">6278112</article-id>
<article-id pub-id-type="publisher-id">3027</article-id>
<article-id pub-id-type="doi">10.1186/s13063-018-3027-3</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Study Protocol</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A multicenter, randomized controlled comparison of three renutrition strategies for the management of moderate acute malnutrition among children aged from 6 to 24 months (the MALINEA project)</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Vray</surname>
<given-names>Muriel</given-names>
</name>
<address>
<email>Muriel.Vray@pasteur.sn</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hedible</surname>
<given-names>Boris G.</given-names>
</name>
<address>
<email>hgildas@hotmail.com</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Adam</surname>
<given-names>Pierrick</given-names>
</name>
<address>
<email>pierrick.adam@pasteur.fr</email>
</address>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tondeur</surname>
<given-names>Laura</given-names>
</name>
<address>
<email>laura.tondeur@pasteur.fr</email>
</address>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Manirazika</surname>
<given-names>Alexandre</given-names>
</name>
<address>
<email>amanirak@yahoo.fr</email>
</address>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Randremanana</surname>
<given-names>Rindra</given-names>
</name>
<address>
<email>rrandrem@pasteur.mg</email>
</address>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mainassara</surname>
<given-names>Halima</given-names>
</name>
<address>
<email>halima@cermes.org</email>
</address>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Briend</surname>
<given-names>André</given-names>
</name>
<address>
<email>andre.briend@gmail.com</email>
</address>
<xref ref-type="aff" rid="Aff6">6</xref>
<xref ref-type="aff" rid="Aff7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Artaud</surname>
<given-names>Cecile</given-names>
</name>
<address>
<email>cecile.artaud@pasteur.fr</email>
</address>
<xref ref-type="aff" rid="Aff8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>von Platen</surname>
<given-names>Cassandre</given-names>
</name>
<address>
<email>cassandre.von-platen@pasteur.fr</email>
</address>
<xref ref-type="aff" rid="Aff8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Altmann</surname>
<given-names>Mathias</given-names>
</name>
<address>
<email>mathias.altmann@u-bordeaux.fr</email>
</address>
<xref ref-type="aff" rid="Aff9">9</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Jambou</surname>
<given-names>Ronan</given-names>
</name>
<address>
<phone>+225 77 92 32 04</phone>
<email>rjambou@pasteur.fr</email>
</address>
<xref ref-type="aff" rid="Aff10">10</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 1956 9596</institution-id><institution-id institution-id-type="GRID">grid.418508.0</institution-id><institution>Unité d’Epidémiologie des Maladies Infectieuses, </institution><institution>Institut Pasteur Dakar, </institution></institution-wrap>Dakar, Senegal </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2353 6535</institution-id><institution-id institution-id-type="GRID">grid.428999.7</institution-id><institution>Unité des Epidémies et des Maladies Emergentes, </institution><institution>Institut Pasteur, </institution></institution-wrap>25 Rue du Dr. Roux, 75015 Paris, France </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.418512.b</institution-id><institution>Unité d’Epidémiologie Institut Pasteur de Bangui, </institution></institution-wrap>Bangui, Central African Republic </aff>
<aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0552 7303</institution-id><institution-id institution-id-type="GRID">grid.418511.8</institution-id><institution>Unité d’Epidémiologie, Institut Pasteur de Madagascar, </institution></institution-wrap>BP1274, 101 Antananarivo, Madagascar </aff>
<aff id="Aff5"><label>5</label>Unité d’Epidémiologie CERMES, Niamey,, Niger </aff>
<aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0674 042X</institution-id><institution-id institution-id-type="GRID">grid.5254.6</institution-id><institution>Department of Nutrition, Exercise and Sports, </institution><institution>Faculty of Science, University of Copenhagen, </institution></institution-wrap>Rolighedsvej 30, DK-1958 Frederiksberg, Denmark </aff>
<aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2314 6254</institution-id><institution-id institution-id-type="GRID">grid.5509.9</institution-id><institution>Tampere Centre for Child Health Research, </institution><institution>University of Tampere, </institution></institution-wrap>Lääkärinkatu 1, 33014 Tampere, Finland </aff>
<aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2353 6535</institution-id><institution-id institution-id-type="GRID">grid.428999.7</institution-id><institution>Centre de recherche Transactionnel, Institut Pasteur, </institution></institution-wrap>28 Rue du Dr. Roux, 75015 Paris, France </aff>
<aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0643 9612</institution-id><institution-id institution-id-type="GRID">grid.452229.a</institution-id><institution>Action Contre la Faim, 14/16 Boulevard Douaumont – CS 80060, </institution></institution-wrap>PARIS CEDEX 17, 75854 Paris, France </aff>
<aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2353 6535</institution-id><institution-id institution-id-type="GRID">grid.428999.7</institution-id><institution>Department of Parasites and Vector Insects, </institution><institution>Institut Pasteur, </institution></institution-wrap>28 Rue du Dr. Roux, 75015 Paris, France </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>4</day>
<month>12</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>4</day>
<month>12</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>19</volume>
<elocation-id>666</elocation-id>
<history>
<date date-type="received">
<day>20</day>
<month>4</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>29</day>
<month>10</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s). 2018</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<sec>
<title>Background</title>
<p id="Par1">The aim of this open-label, randomized controlled trial conducted in four African countries (Madagascar, Niger, Central African Republic, and Senegal) is to compare three strategies of renutrition for moderate acute malnutrition (MAM) in children based on modulation of the gut microbiota with enriched flours alone, enriched flours with prebiotics or enriched flours coupled with antibiotic treatment.</p>
</sec>
<sec>
<title>Methods</title>
<p id="Par2">To be included, children aged between 6 months and 2 years are preselected based on mid-upper-arm circumference (MUAC) and are included based on a weight-for-height Z-score (WHZ) between − 3 and − 2 standard deviations (SD). As per current protocols, children receive renutrition treatment for 12 weeks and are assessed weekly to determine improvement. The primary endpoint is recovery, defined by a WHZ ≥ − 1.5 SD after 12 weeks of treatment. Data collected include clinical and socioeconomic characteristics, side effects, compliance and tolerance to interventions. Metagenomic analysis of gut microbiota is conducted at inclusion, 3 months, and 6 months. The cognitive development of children is evaluated in Senegal using only the Developmental Milestones Checklist II (DMC II) questionnaire at inclusion and at 3, 6, and 9 months. The data will be correlated with renutrition efficacy and metagenomic data.</p>
</sec>
<sec>
<title>Discussion</title>
<p id="Par3">This study will provide new insights for the treatment of MAM, as well as original data on the modulation of gut microbiota during the renutrition process to support (or not) the microbiota hypothesis of malnutrition.</p>
</sec>
<sec>
<title>Trial registration</title>
<p id="Par4">ClinicalTrials.gov, ID: <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT03474276?term=malinea&amp;rank=1">NCT03474276</ext-link> Last update 28 May 2018.</p>
</sec>
<sec>
<title>Electronic supplementary material</title>
<p>The online version of this article (10.1186/s13063-018-3027-3) contains supplementary material, which is available to authorized users.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Moderate acute malnutrition</kwd>
<kwd>Prebiotic</kwd>
<kwd>Azithromycin</kwd>
<kwd>Microbiota</kwd>
<kwd>Metagenomic</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution>MEAE</institution>
</funding-source>
<award-id>2101375618</award-id>
<principal-award-recipient>
<name>
<surname>Jambou</surname>
<given-names>Ronan</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>Action contre la Faim</institution>
</funding-source>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Background</title>
<p id="Par23">The main objective of this study is to improve the nutrition strategy used to treat moderate acute malnutrition (MAM). This is based on modulation of the gut microbiota with an adjunct product added to standard nutrition flours.</p>
<sec id="Sec2">
<title>Undernutrition in Africa</title>
<p id="Par24">Child malnutrition in intertropical zones is a major public health problem. It favors the appearance of diarrhea but can also (1) disrupt the response to infection [<xref ref-type="bibr" rid="CR1">1</xref>], (2) lead to an imbalance of the commensal flora and inflammation [<xref ref-type="bibr" rid="CR2">2</xref>], and (3) modulate the response to vaccines [<xref ref-type="bibr" rid="CR3">3</xref>]. These changes may also alter the cognitive development of children. Due to its life-threatening impact, programs provide care mainly for severe acute malnutrition (SAM), which is frequent in disturbed political contexts such as the Central African Republic (CAR) or during crop failure related to drought, like in Sahel. For example, in Niger, <italic>Action Contre la Faim</italic> Network (ACF) had to deal with 400,000 cases of SAM in 2013. However, aside from the emergency situation, SAM can develop in a context of chronic malnutrition (CM), such as in Madagascar, where 47.4% of children aged under 5 years are stunted [<xref ref-type="bibr" rid="CR4">4</xref>]. MAM often happens during the first years of life when food is introduced in complement to breast milk. It can be managed at home and not at the hospital. However, if the management of the MAM changes over the last 30 years, the composition of flours has remained virtually unchanged. Indeed the time to recover is still long, and the percentage of success can be low [<xref ref-type="bibr" rid="CR5">5</xref>], with high default rates or nonresponse to treatment, low coverage, and high associated costs [<xref ref-type="bibr" rid="CR6">6</xref>–<xref ref-type="bibr" rid="CR8">8</xref>].</p>
</sec>
<sec id="Sec3">
<title>Malnutrition and microbiota</title>
<p id="Par25">Related to poverty and poor access to sanitation, infectious diseases are responsible for 25% of deaths worldwide, and diarrhea is the third deadliest infection, with approximately 525,000 per year for children aged under 5 years [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. Diarrhea can modulate gut microbiota [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>] but an effect of an imbalance in the gut microbiota, regardless of diarrhea, on long-term child growth can also be important. This gut microbiota accounts for approximately 10<sup>12</sup> microorganisms in humans, including bacteria, archae, yeast, viruses, and parasites. Gut microbiota can establish early in a child’s life (may be even during pregnancy and delivery) and it can modulate diseases [<xref ref-type="bibr" rid="CR13">13</xref>]. It changes greatly with the introduction of food [<xref ref-type="bibr" rid="CR14">14</xref>]. Its composition also varies between industrialized and low/middle-income countries (LMICs) with an increased abundance of <italic>Prevotella</italic> species in developing countries compared to an increased abundance of <italic>Bacteroides</italic> in developed countries. [<xref ref-type="bibr" rid="CR15">15</xref>–<xref ref-type="bibr" rid="CR17">17</xref>]. In LMICs, urease-positive strains are enriched, indicating adaptations to the low-protein food that is consumed [<xref ref-type="bibr" rid="CR17">17</xref>].</p>
<p id="Par26">Recent studies have shown a link between SAM and the colonic microbiota composition [<xref ref-type="bibr" rid="CR18">18</xref>–<xref ref-type="bibr" rid="CR24">24</xref>]. During the first years of life, children with SAM have a significant delay in the maturation of the microbiota [<xref ref-type="bibr" rid="CR23">23</xref>]. Changes in microbiota composition lead to “dysbiosis,” marked by the enhancement of gut permeability and inflammation [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>]. Indeed, chronic inflammation induced by permanent stimulation due to food heavily contaminated by nonpathogenic or pathogenic bacteria could associated with villous atrophy, anorexia and malnutrition. These changes in microbiota could be a decrease in diversity or a shift in its composition as described in acute gastrointestinal infection [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR28">28</xref>], inflammatory bowel disease [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>], coeliac disease [<xref ref-type="bibr" rid="CR31">31</xref>–<xref ref-type="bibr" rid="CR35">35</xref>], colon and liver cancer [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>], obesity [<xref ref-type="bibr" rid="CR38">38</xref>], and diabetes [<xref ref-type="bibr" rid="CR39">39</xref>].</p>
<p id="Par27">The microbiota of non-stunted children looks enriched in probiotic species <italic>Bifidobacterium longum</italic> and <italic>Lactobacillus mucosae</italic>, whereas that of stunted children was enriched in inflammogenic taxa, including those in the genus <italic>Desulfovibrio</italic> and the order <italic>Campylobacterales</italic> [<xref ref-type="bibr" rid="CR40">40</xref>]. Along the same line of reasoning, the metabolic impact of parasites such as <italic>Isospora belli</italic>, <italic>Cyclospora</italic>, <italic>Cryptosporidium</italic>, and <italic>Microsporidia</italic> in malnourished persons seems largely underresearched, but <italic>Giardia</italic> was recently associated with malnutrition [<xref ref-type="bibr" rid="CR41">41</xref>].</p>
<p id="Par28">During malnutrition, the disturbance of immunity may alter the response to vaccines, especially those administered orally (poliovirus, rotavirus, etc.) [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. This reduced efficacy was confirmed during severe malnutrition, but is still being debated regarding moderate and chronic malnutrition. The impact of microbiota on brain function is also a major focus of research [<xref ref-type="bibr" rid="CR42">42</xref>–<xref ref-type="bibr" rid="CR46">46</xref>].</p>
</sec>
<sec id="Sec4">
<title>How to modulate the microbiota: antibiotics versus prebiotics</title>
<p id="Par29">In malnourished children, clinical signs of infection can be attenuated. Indeed, the WHO recommends treatment of severely malnourished children with antibiotics [<xref ref-type="bibr" rid="CR47">47</xref>]. Compared to standard flours, an increase in weight gain was described for children treated with flours + antibiotics [<xref ref-type="bibr" rid="CR48">48</xref>]. In Malawi, a short-term effect of antibiotics on the nutritional recovery rate and mortality rate was confirmed for children with SAM [<xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR50">50</xref>]. In Malawi, no effect of rifamixin on intestinal permeability was observed [<xref ref-type="bibr" rid="CR49">49</xref>], whereas in Niger (Epicentre study), amoxicillin did not show any short-term benefit on the recovery rate of SAM compared with placebo [<xref ref-type="bibr" rid="CR51">51</xref>]. However, hospital transfer rates decreased significantly. In Kenya, cotrimoxazole also failed to improve the clinical status of children with SAM [<xref ref-type="bibr" rid="CR52">52</xref>]. The antibiotics can destroy gut microflora, but the effect on intestinal barrier integrity is still being debated [<xref ref-type="bibr" rid="CR53">53</xref>].</p>
<p id="Par30">Antibiotics can also restore equilibrium between the bacterial population induced by pathogenic bacteria. This has been described in the case of cholera, as a vibrio infection, and it results in a decrease in <italic>Bacteroidetes</italic>, <italic>Firmicutes</italic>, and <italic>Actinobacteria</italic> and an increase in harmful <italic>Proteobacteria</italic>. This disequilibrium was approached with treatment with macrolides; the abundance of <italic>Escherichia coli</italic>, <italic>Enterococcus</italic>, and <italic>Veillonella</italic> increased, while that of <italic>Bifidobacteria</italic>, <italic>Bacteroides</italic>, and <italic>Ruminococcus</italic> decreased [<xref ref-type="bibr" rid="CR54">54</xref>].</p>
<p id="Par31">However, the use of antibiotics for SAM children, even though recommended by the WHO, remains debated [<xref ref-type="bibr" rid="CR55">55</xref>–<xref ref-type="bibr" rid="CR59">59</xref>] both for its efficacy and for the possible increase in drug resistance [<xref ref-type="bibr" rid="CR60">60</xref>]. To date, no trials have been performed on antibiotic use among MAM children. <italic>Firmicutes</italic> and other common gut microorganisms can contribute to fight by themselves against pathogens by local production of bacteriocins [<xref ref-type="bibr" rid="CR61">61</xref>].</p>
<p id="Par32">In the MALINEA (<italic>Malnutrition et Infection de l’Enfance en Afrique</italic>) protocol, macrolides were chosen to treat MAM based on (1) a narrower antibacterial spectrum of activity than other widely used antibiotics, (2) a rare use in dispensaries, especially as first-line treatment, which will prevent the emergence of resistant strains during mass administration, and (3) a favorable side-effect profile [<xref ref-type="bibr" rid="CR62">62</xref>]. The main side effect of macrolides is gastrointestinal disturbance, which is less prevalent with azithromycin than with clarithromycin. For azithromycin, a long half-life and activity allows a 3-day treatment with a single daily dose (20 mg/kg/day). Anti-inflammatory and immunomodulatory activities have also been reported. A benefit was also reported on neonatal growth when given to the mother [<xref ref-type="bibr" rid="CR63">63</xref>]. In line, the recent MORDOR trial [<xref ref-type="bibr" rid="CR64">64</xref>] showed the benefit of azithromycin alone on the mortality and clinical status of children.</p>
<p id="Par33">Microbiota can also be modulated through several very different compounds called probiotics [<xref ref-type="bibr" rid="CR65">65</xref>], prebiotics, and milk oligosaccharides [<xref ref-type="bibr" rid="CR66">66</xref>]. Microbiota transplantation can also be used but is still experimental [<xref ref-type="bibr" rid="CR67">67</xref>].</p>
<p id="Par34">For probiotics (a specific strain of bacteria inoculated orally to the patient), the choice of species and, even more, the choice of strain to use, are very important and remain pitfalls for clinical trials [<xref ref-type="bibr" rid="CR68">68</xref>]. The benefit of combination of probiotics + prebiotics can also be questioned, as in the PRONUT study [<xref ref-type="bibr" rid="CR69">69</xref>].</p>
<p id="Par35">On the other hand, prebiotics are mostly nondigestible carbohydrates, which serve as substrates, and they support proliferation of certain bacteria, such as bifidobacteria and lactobacilli. Early in life, they are provided by maternal milk through breast-feeding at the same time as commensal bacteria [<xref ref-type="bibr" rid="CR70">70</xref>].</p>
<p id="Par36">Unlike antibiotics, prebiotics do not modify the existing strains of bacteria but impact the proportions of the different groups of bacteria in the intestine (gut microbiota). The best-known prebiotics are (1) fructans (fructose polymers including inulin), which are present in many plants and extracted from chicory tubers [<xref ref-type="bibr" rid="CR71">71</xref>], (2) fructo-oligosaccharides (FOS), obtained by hydrolysis of inulin or by biosynthesis from sucrose, and (3) fructose/galactose-containing oligosaccharides (galacto-oligosaccharides, GOS), which are natural products of human breastmilk. In children, most studies have used combinations of inulin and GOS [<xref ref-type="bibr" rid="CR72">72</xref>]. Depending on the microbiota, they reach more or less distal parts of the colon before being metabolized by the resident bacteria [<xref ref-type="bibr" rid="CR73">73</xref>, <xref ref-type="bibr" rid="CR74">74</xref>]. Prebiotics have been associated in several studies with profound changes in the microbial ecology of the gut and in a shift towards “healthier” communities [<xref ref-type="bibr" rid="CR75">75</xref>]. Many studies have been conducted in animals and in human adults [<xref ref-type="bibr" rid="CR76">76</xref>], and recent studies support a beneficial effect for HIV-infected children. In studies performed so far using the prebiotic inulin, the proportion of <italic>Lactobacillus</italic> spp., <italic>Bifidobacterium</italic> spp. [<xref ref-type="bibr" rid="CR77">77</xref>, <xref ref-type="bibr" rid="CR78">78</xref>], and <italic>Faecalibacterium prausnitzii</italic> [<xref ref-type="bibr" rid="CR75">75</xref>, <xref ref-type="bibr" rid="CR79">79</xref>, <xref ref-type="bibr" rid="CR80">80</xref>] was shown to be increased during treatments, while the growth of <italic>Enterobacteriaceae</italic> and <italic>Clostridium</italic> spp. seemed to be restricted [<xref ref-type="bibr" rid="CR78">78</xref>, <xref ref-type="bibr" rid="CR80">80</xref>, <xref ref-type="bibr" rid="CR81">81</xref>]. Prebiotics seemed to modulate lymphoid tissue associated with the intestine, resulting in improvement of inflammatory bowel symptoms in children or post-vaccine responses against measles [<xref ref-type="bibr" rid="CR82">82</xref>–<xref ref-type="bibr" rid="CR85">85</xref>]. Inulin consumption may improve the absorption of minerals in the colon, such as calcium, magnesium, zinc, and iron [<xref ref-type="bibr" rid="CR86">86</xref>–<xref ref-type="bibr" rid="CR88">88</xref>].</p>
</sec>
<sec id="Sec5">
<title>Cognitive impairment</title>
<p id="Par37">Malnutrition is frequently associated with cognitive delay, compromising child development and education [<xref ref-type="bibr" rid="CR89">89</xref>, <xref ref-type="bibr" rid="CR90">90</xref>]. An effect of the modulation of microbiota in the development of cognitive function in children can be suspected [<xref ref-type="bibr" rid="CR91">91</xref>, <xref ref-type="bibr" rid="CR92">92</xref>]. Deworming by itself can affect the cognitive skills of children [<xref ref-type="bibr" rid="CR93">93</xref>] but this could be due to an indirect effect on iron and anemia. The opportunity for modulating the intestinal microbiota, diarrhea or cognitive development with pre- or probiotics is also under study [<xref ref-type="bibr" rid="CR94">94</xref>–<xref ref-type="bibr" rid="CR97">97</xref>].</p>
</sec>
<sec id="Sec6">
<title>Malnutrition is a major health problem in the four countries involved in the project</title>
<p id="Par38">The choice of the four countries in which to conduct this research is based on epidemiological data on moderate malnutrition, on existing facilities supported by ACF in the field and on the ability to perform high-level biological analysis in local laboratories. The countries selected in this project are particularly vulnerable to malnutrition and diarrhea. Programs are supported either by local facilities or through nongovernmental organizations (NGOs), especially ACF.</p>
<p id="Par39">In Madagascar [<xref ref-type="bibr" rid="CR4">4</xref>], acute malnutrition affects 8.6% of children aged under 5 years, including 1.4% with severe forms. At weaning, the majority of children benefit from the introduction of food supplements but have a poorly diversified diet. Growth retardation begins in utero (13% of children weigh less than 2.5 kg at birth) and increases at 12 months of age. Micronutrient deficiency is also a major public health problem in Madagascar that could increase the risk of morbidity and mortality [<xref ref-type="bibr" rid="CR4">4</xref>].</p>
<p id="Par40">In Niger, global acute malnutrition (GAM) has remained above the alert threshold (10%) in recent years among children aged 6–59 months. For children aged 6 to 23 months, malnutrition regularly exceeds the emergency threshold of 15%, as in 2005, 2010 (22%), and 2011 (20.2%). During the last 5 years, chronic malnutrition (CM) or growth retardation affected one of every two children in the country [<xref ref-type="bibr" rid="CR97">97</xref>]. The overall underweight (weight- for-age) prevalence ranged between 32 and 40% over the past 5 years [<xref ref-type="bibr" rid="CR98">98</xref>–<xref ref-type="bibr" rid="CR101">101</xref>].</p>
<p id="Par41">In 2014, in Senegal, the prevalence of GAM at the national level was 8.8%. The prevalence in some departments, such as Ranérou, Podor, and Kanel, exceeds the critical threshold of 15%. Sixteen departments of 45 have exceeded the threshold of 10% GAM. Chronic malnutrition affects 15.5% of children aged 0–59 months [<xref ref-type="bibr" rid="CR102">102</xref>].</p>
<p id="Par42">In the CAR, in 2012, at a national level, the GAM prevalence rate was 8%, and the SAM rate was 1.9%. The CM rate was 38.7% [<xref ref-type="bibr" rid="CR103">103</xref>, <xref ref-type="bibr" rid="CR104">104</xref>]. In addition to the progressive reopening of nutrition centers, mobile clinics are organized to screen children among the displaced in Bangui (639,000 displaced people; i.e., 12% of the total population) [<xref ref-type="bibr" rid="CR105">105</xref>]. The country is in crisis, and only NGO interventions cover these emergencies [<xref ref-type="bibr" rid="CR106">106</xref>].</p>
</sec>
</sec>
<sec id="Sec7">
<title>Methods and design</title>
<sec id="Sec8">
<title>The aim</title>
<p id="Par43">The aim of this project is to define an easy-to-use modified strategy of renutrition to use in primary health centers to treat MAM before it degenerates into SAM. The main problem to tackle is that, in a peri-urban context, alimentation of small children is difficult to manage accurately, especially when food (or financial) resources are limited.</p>
</sec>
<sec id="Sec9">
<title>The objectives</title>
<p id="Par44">The general objective of this project is to improve nutrition for children with moderate malnutrition using strategies to modulate intestinal microbiota. The objective of this three-arm, open-label, randomized multicountry study is to evaluate the effectiveness of two improved strategies of management of MAM in children aged between 6 months and 2 years in comparison with a reference standard of care. Recovery is defined by a (weight-for-height Z-score) WHZ ≥ − 1.5 standard deviations (SD) after 3 months of treatment.</p>
<p id="Par45">The secondary objectives are (1) to compare, for each group, all the measurements before and 3 months after intervention (weight, length, mid-upper-arm circumference (MUAC)); (2) to compare, between the three groups, the occurrence of clinical outcomes (intercurrent illness, hospitalization and transfer to the next level of care), the compliance to protocol, and tolerance (reported adverse and side effects, duration and intensity); and (3) to analyze the gut microbiota of the children during the renutrition process. In Senegal, psychomotor development will be assessed at inclusion and 3, 6, and 9 months after intervention using the DMC II (Developmental Milestones Checklist). DMC II scores will be compared (1) for the same child before and after intervention, (2) at inclusion between matched healthy children and malnourished ones from the same district, and (3) between arms at 3, 6, and 9 months.</p>
</sec>
<sec id="Sec10">
<title>The study design (protocol version 2_ 28 February 2018)</title>
<p id="Par46">According to centralized randomization, the children will receive one of the following:<list list-type="bullet"><list-item><p id="Par47">Arm 1 (control): malted milk <italic>Prise en Charge de la</italic> MAM (PEC-MAM) flour + antiparasitic (albendazole)</p></list-item><list-item><p id="Par48">Arm 2 (antibiotic): malted milk PEC-MAM flour + antiparasitic (albendazole) + azithromycin for 3 days</p></list-item><list-item><p id="Par49">Arm 3 (prebiotic): malted milk PEC-MAM flour + antiparasitic (albendazole) + inulin/FOS mixed with flour</p></list-item></list></p>
<p id="Par50">A control group of well-nourished children without diarrhea aged 18 to 24 months will also be included to match the malnourished ones but without follow-up visits. The objective is to investigate microbiota of well-nourished children living in the same place and at the same time as the case group, to take into account local and seasonal variation of the microbiota. As only one stool sample will be obtained from non-stunted children, children under 18 months will not be included to discard the fluctuating composition of the microbiota at such young ages.</p>
</sec>
<sec id="Sec11">
<title>Participants and enrollment</title>
<p id="Par51">In Niger, the study will be conducted in the department of Mayahi, in the municipalities of Tchake and Issawanne. In Tchake, the total population is 28,338 inhabitants, with 5668 children aged less than 5 years, and in Issawanne, the total population is of 45,152 inhabitants, with 9030 children aged under 5 years.</p>
<p id="Par52">In Senegal, recruitment will be conducted in the district of Guédiawaye, near Dakar. The district is a low-income area of 355,525 inhabitants, with an average rate of MAM of 6%. The primary health care center will be <italic>Hamo V</italic>, where an average of 500 MAM cases are followed each semester. A large team of community relay agents, led by nurses from the primary health care center, is in charge of the screening of MAM in the community.</p>
<p id="Par53">In Madagascar, the study will take place in poor neighborhoods of Antananarivo. Two different structures run by local NGOs (CRENAM Andohotapenaka) and Centre de Santé Mitia are dealing with malnourished children.</p>
<p id="Par54">In the CAR, the study will take place in Bangui in two private centers that support MAM: the St. Jacques and the St. Joseph’s Health Centres. These centers are supported by the World Food Program, which provides nutritional supplements.</p>
<p id="Par55">Prescreening of malnourished children aged between 6 and 24 months will be conducted in the country by community health workers using arm circumference (115 ≤ MUAC &lt; 130 mm). To be definitively included, children should have a WHZ between − 3 and − 2 SD, and should be followed for at least 3 months. Written consent from the parents or legal guardians will be obtained. Children not satisfying these criteria will not be included, nor will those (1) with complications requiring intensive clinical care (severe vomiting, hypothermia &lt; 35 °C or fever &gt; 39 °C, pneumonia, and severe anemia), (2) with extensive infections, (3) who are weak, apathetic or unconscious, and (4) or presenting fitting/convulsions, severe dehydration or any condition that requires an infusion or tube feeding. Children currently receiving one of the following treatments will also be excluded from entering the study: antacids, cetirizine, digoxin, ergotamine, zidovudine. Moreover, those with hypersensitivity to macrolides, flour or the prebiotics used during the study will also be excluded. HIV testing is not planned as its prevalence is very low in three countries out of four. For CAR systematic testing of young children for HIV was considered as a stigmatization of the mother by the National Ethic Committee which will induce refusal of the mothers to participate.</p>
</sec>
<sec id="Sec12">
<title>Recruitment, randomization, and follow-up (Fig. <xref ref-type="fig" rid="Fig1">1</xref> and Additional file <xref ref-type="media" rid="MOESM1">1</xref>)</title>
<p id="Par56">The enrollment will take place at the primary health center after weight and height assessment, signature of written consent from the parent or legal guardian, and verification of inclusion/exclusion criteria.<fig id="Fig1"><label>Fig. 1</label><caption><p>Timetable of the follow up of the children</p></caption><graphic id="MO1" xlink:href="13063_2018_3027_Fig1_HTML"></graphic></fig></p>
<p id="Par57">Randomization will be stratified by country, health center, and age (6–11 months versus 12–24 months). Randomization will be achieved in a 1:1 ratio using random permutation blocks. A clinical examination will be done, and stool samples will be collected. Systematic treatment with albendazole will be given to all children in the three arms aged older than 12 months after collection of the stools. For children treated with azithromycin, the first treatment will be given after stool collection at the dispensary. Doses for the following 2 days will be given at the health center as well.</p>
<p id="Par58">After enrollment, in Senegal, children with MAM will be evaluated for cognitive development and ability, with a DMC II (Developmental Milestones Checklist) questionnaire applied by a trained social worker.</p>
<p id="Par59">Children will be followed up weekly for 12 weeks and at 6 months (M6) at the health center. At each visit, (1) flours will be given to the caretaker for the whole week, (2) weight, height, and arm circumference will be assessed, and (3) a clinical examination will be carried out, and data on safety and child’s food consumption will be investigated. In the case of a missing visit or insufficient weight gain, a visit at home will be organized by health workers to collect supplementary information.</p>
<p id="Par60">At inclusion, 3 months (M3) and 6 months (M6), stool samples will be collected. After 6 months, the follow-up will be stopped except for in children involved in the psychomotor development evaluation protocol, who will be followed until age 9 months (M9). However, in the case of nonrecovery at M3, children will still receive follow-up care according to the national recommendations but will be considered “treatment failure.”</p>
</sec>
<sec id="Sec13">
<title>Interventions</title>
<sec id="Sec14">
<title>Supplementary feeding</title>
<p id="Par61">Default of quality of flours obtained from the local market in African countries is a very common pitfall that is poorly addressed by NGOs. For the trial, flours will be produced by an industrial partner <italic>(</italic>PROTEIN KISSEE LA <italic>Zone industrielle, Vridi, Port-Bouet, 18 BP 2335 Abidjan</italic>). It is a well-established brand on the West African market providing ready-to-eat fortified complementary foods. The composition of the flours, described in Table <xref ref-type="table" rid="Tab1">1</xref>, will be adapted to the international malted milk PEC-MAM standard [<xref ref-type="bibr" rid="CR107">107</xref>].<table-wrap id="Tab1"><label>Table 1</label><caption><p>Composition of the flours</p></caption><table frame="hsides" rules="groups"><thead><tr><th></th><th>Without prebiotics</th><th>With prebiotics</th><th></th></tr></thead><tbody><tr><td colspan="4">Composition (% of dry weight)</td></tr><tr><td> wheat</td><td>62.4%</td><td>60.9%</td><td></td></tr><tr><td> soya</td><td>20.8%</td><td>20.3%</td><td></td></tr><tr><td> sugar</td><td>8%</td><td>8%</td><td></td></tr><tr><td> dry milk</td><td>7%</td><td>7%</td><td></td></tr><tr><td> iodinated salt</td><td>0.2%</td><td>0.2%</td><td></td></tr><tr><td> vitamins and salts</td><td>1.3%</td><td>1.3%</td><td></td></tr><tr><td> flavor</td><td>0.4%</td><td>0.4%</td><td></td></tr><tr><td> Prebiotic</td><td>0%</td><td>2%</td><td></td></tr><tr><td>Total</td><td>100%</td><td>100%</td><td></td></tr><tr><td colspan="4">Overall composition of the flour and additional compounds (for both with and without prebiotic): composition per 100 g of flour</td></tr><tr><td> calories (kcal)</td><td>420</td><td>ascorbic acid</td><td>60</td></tr><tr><td> protein total (g)</td><td>15</td><td>thiamin</td><td>1</td></tr><tr><td> lipids (g)</td><td>9</td><td>riboflavin</td><td>1</td></tr><tr><td> carbohydrates</td><td>66</td><td>nicotinamide (mg)</td><td>12</td></tr><tr><td> fibers</td><td>2</td><td>folic acid (mg)</td><td>0.3</td></tr><tr><td> sodium (mg)</td><td>200</td><td>pantothenic acid (mg)</td><td>4</td></tr><tr><td> calcium mg)</td><td>266</td><td>biotin (μg)</td><td>0.016</td></tr><tr><td> phosphorus (mg)</td><td>200</td><td>vitamin E (IU)</td><td>10</td></tr><tr><td> potassium (mg)</td><td>610</td><td>vitamin B12 (μg)</td><td>1.8</td></tr><tr><td> iron (mg)</td><td>23.2</td><td>vitamin A (IU)</td><td>2668</td></tr><tr><td> copper (mg)</td><td>0.18</td><td>vitamin D (IU)</td><td>400</td></tr><tr><td> zinc (mg)</td><td>16.6</td><td>vitamin B6 (mg)</td><td>1</td></tr><tr><td> manganese (mg)</td><td>2.4</td><td></td><td></td></tr></tbody></table></table-wrap></p>
</sec>
<sec id="Sec15">
<title>Antibiotics</title>
<p id="Par62">A vial of powder for oral suspension of azithromycin (600 mg) will be restored at 200 mg/5 mL and then given with a syringe for oral administration three times once a day over a maximum of 4 days (in case of 1 day missing) (20 mg/kg/day daily for 3 days). The same batch of antibiotics will be used in the four countries.</p>
</sec>
<sec id="Sec16">
<title>Prebiotics</title>
<p id="Par63">The recommended doses with positive effects on the intestinal flora are between 2.5 to 10 g/day [<xref ref-type="bibr" rid="CR108">108</xref>, <xref ref-type="bibr" rid="CR109">109</xref>]. The main side effects are observed with doses more than 40 g/day, as the substances can cause bloating and induce intestinal cramps. Abdominal pain has been reported with doses of 10 g/day. For this study, we will evaluate the effectiveness of a combination of prebiotic inulin / FOS (Synergy1 6 g/day if age ≥ 12 months and 4 g/day if &lt; 12 months), as it is simple to be obtained (manufactured by BENEO, Tienen, Belgium) and is active at different levels of the digestive tract.</p>
</sec>
</sec>
<sec id="Sec17">
<title>Data collection</title>
<sec id="Sec18">
<title>Clinical data</title>
<p id="Par64">At inclusion, a standardized questionnaire will be conducted with the parents or legal guardians to collect general characteristics, socioeconomic and clinical data.</p>
<p id="Par65">At each visit, clinical assessment will be recorded until recovery and then at M6, data will be registered concerning undercurrent illness, signs of infections (diarrhea, vomiting, fever, cough), need to transfer to hospital, and safety and adherence to treatments (defined as completion of all 7 days of the study regimen).</p>
</sec>
<sec id="Sec19">
<title>Anthropometric data</title>
<p id="Par66">The children will be monitored weekly for 3 months (or until recovery if treatment fails) at the primary health center. One additional visit is planned at 6 months. At each visit, weight, length, and MUAC will be measured. Balances will be from SECA UNICEF (± 100 g). Length will be measured on children placed in an elongated position using a Fathom Infant / Child ShorrBoard for infants aged less than 2 years (130 cm with graduations of 0.1 cm). MUAC will be measured with a UNICEF MUAC tape.</p>
</sec>
<sec id="Sec20">
<title>Laboratory processes</title>
<p id="Par67">Stool samples will be collected during the day and stored at 4 °C until transportation to the laboratory. At laboratory, stools will be separated in aliquots and stored at − 80 °C until analysis. Stool examination will be based on metagenomic approaches. Whole deoxyribonucleic acid (DNA) will be extracted from stools using a procedure adapted for stools including bead fractioning and a QIAGEN stool extraction kit. Fragments of the 16S gene will be polymerase chain reaction (PCR) amplified using V3/V4-adapted primers. Sequencing of the PCR products will be carried out on a Miseq Illumina machine. Metagenomic analysis will be conducted using the SHAMANN package. In parallel, direct detection of pathogens (<italic>Salmonella</italic>, STEC, <italic>Campylobacter</italic>, <italic>Vibrio cholerae</italic>, <italic>V parahaemolyticus</italic>, <italic>V vulnificus</italic>, <italic>Cryptosporidium</italic> sp., <italic>Entamoeba histolytica</italic>, <italic>Giardia lamblia</italic>, Microsporides sp., Adenovirus, Astrovirus, Norovirus, Rotavirus) will be done using specific quantitative-PCR (Q-PCR) and ELISA protocols in the <italic>Institut Pasteur de Madagascar, Institut Pasteur de Dakar</italic>, and <italic>Institut Pasteur de Bangui.</italic></p>
</sec>
<sec id="Sec21">
<title>Cognitive and motor development</title>
<p id="Par68">During this study, a Developmental Milestones Checklist II (DMC II) questionnaire will be administered to participating children to evaluate their cognitive and motor abilities. This questionnaire is adapted to children aged between 1 and 59 months and has been developed specifically to be used in developing countries and particularly in sub-Saharan Africa.</p>
<p id="Par69">In Senegal, the DMC II will be applied during enrollment at inclusion and 3, 6, and 9 months, after enrollment. Eighty children with MAM and 80 healthy non-stunted children will be included in this specific phase. This questionnaire has already been used in several countries (Kenya, Bukina Faso, Mali). It can be applied by trained but unspecialized field workers and is fast to document (20–30 min). Adaptation of the questionnaire to the local context will be done during a preliminary study conducted at the Children’s Hospital of Dakar.</p>
</sec>
</sec>
<sec id="Sec22">
<title>Evaluation criteria</title>
<p id="Par70">The primary endpoint is recovery, defined by WHZ &gt; − 1.5 SD at two successive examinations without hospitalization or undercurrent discharge to SAM or lost to follow-up. The main endpoint will be at 3 months. This is a stronger criteria of recovery than usual (WHZ &gt; − 2), which avoids misclassification of the children at the end of the intervention.</p>
<p id="Par71">Secondary outcomes include anthropometric parameters (weight, length, and MUAC), time for recovery, and safety of the strategy, compliance to treatment and psychomotor development evolution (for Senegalese children).</p>
<p id="Par72">The main biological secondary endpoint is to analyze the variations of microbiota and the presence of specific pathogens during the renutrition process. The major question is to understand if microbiota differ between well- and malnourished children and if renutrition retardation is related to a specific type of microbiota. Microbiota will be expressed as Operational Taxonomic Units (OTUs), and the results of Q-PCR as positive/negative.</p>
</sec>
<sec id="Sec23">
<title>Statistical considerations</title>
<p id="Par73">Full details on data management and the database can be available on reasonable request to the corresponding author. Databases and confidentiality purposes were already approved by either the National Ethics Committees, the Pasteur Institute IRB or the French Office for Safety in Data Meaning (CNIL).</p>
<sec id="Sec24">
<title>Sample size</title>
<p id="Par74">Based on previous studies showing a recovery rate of between 50 and 88%, we can assume a likelihood of nutritional recovery in the control arm of approximately 60% after 12 weeks. To show a benefit of at least 15% with antibiotics or prebiotics, with a type I error of 0.017 (Bonferroni correction for multiple comparisons), a power of 90% and a two-sided test, 840 children will be enrolled (280 per arm), with 210 in each country (with an allowance to loss of 10%). After enrollment, in Senegal, 80 children with MAM will be evaluated and followed for their cognitive development and ability.</p>
</sec>
<sec id="Sec25">
<title>Statistical analysis</title>
<p id="Par75">The primary endpoint will be analyzed using both the intention-to-treat population (children lost to follow-up or referred at hospital considered as failures) and the per- protocol population (including only children without protocol deviation). A third analysis will be conducted using the last value available (endpoint analysis). A chi-squared test will be used to compare the primary endpoint (recovery at 3 months) between the three groups.</p>
<p id="Par76">To take into account the time to recovery, a survival analysis will be performed using a Cox model with adjustment for center and age. Comparisons will be also performed for the other anthropometric criteria (weight, height, MUAC, weight gain) as well as for a DMC II test using a mixed linear model for repeated measurements.</p>
</sec>
<sec id="Sec26">
<title>Bioinformatic analysis</title>
<p id="Par77">For the stool samples, bioinformatics analysis will be conducted to identify the species present in each sample. As many species can exist in the same sample, samples will be clustered in “profiles” of composition using principal component analysis. In the first step, these profiles will be considered classes of a parameter called “microbiota.” However, some specific species could impact the renutrition process more deeply. A second round of analysis will be conducted using the species themselves, taking into account the comparison of groups of children with rapid versus slow recovery. At the time of inclusion (day 0), analysis will focus on (1) comparison of microbiota between countries, (2) association of some socioeconomic parameters with some specific profile of microbiota (all countries together), and (3) differences in microbiota between children with or without malnutrition (for children aged over 18 months). During the time course of the renutrition process, comparison of microbiota will be done (1) between the arms of treatment, (2) between children with and without recovery, and (3) between children with slow and fast recovery.</p>
</sec>
</sec>
</sec>
<sec id="Sec27">
<title>Discussion</title>
<p id="Par78">Child malnutrition is a major public health problem in intertropical zones, but most of the resources and studies focus on SAM due to its life-threatening impact. However, SAM develops most often with chronic malnutrition that can lead to moderate acute malnutrition during shortening of family resources or during child infections, before worsening into SAM. MAM thus has a heavy impact on national health structures, as the number of children involved is usually higher than that for SAM, and acting effectively on MAM could prevent having to treat more SAM. The delay in seeking treatment is also often long, causing the situation to worsen and complicating treatment. Compliance to treatment is also a challenge. Facing these problems, almost no change in the strategy of treatment has been validated for the last 30 years. Decreasing the time of treatment and improving the efficacy could be major achievements.</p>
<p id="Par79">MAM occurrence is almost exclusively restricted to the first 24 months of life, closely relating to the time when foods complementary to breast milk are introduced. However, recent studies on gut physiology have drawn attention to the role of dis-equilibrated gut microbiota both in malnutrition and obesity. We decided to use two strategies (prebiotics and antibiotics) to modulate the microbiota while providing renutrition with flours.</p>
<p id="Par80">A short-term effect of antibiotics on nutritional recovery rate was observed in children treated for severe malnutrition. The effect on MAM could be similar. On the other hand, prebiotics serve as substrates and induce proliferation of bifidobacteria and lactobacilli, changing the proportions of different groups of bacteria in the gut. Other strategies could be envisioned, such as the use of anti-oxidants, specific micronutrients, etc.</p>
<p id="Par81">Overall, we currently have only a partial understanding of interactions between nutrients, gut microorganisms and the immune system. Thus, we have chosen a pragmatic approach for the MALINEA study with two strategies targeting the gut microbiota in a broad manner. They are safe and practical to use at the community level in LMICs. Considering the large number of children concerned, criteria such as low prices, ease of use, and potential availability of local production, are very important for the choice of a strategy.</p>
<p id="Par82">This three-armed randomized intervention will be evaluated by effects both on the children’s anthropometric parameters and on their microbiota, providing first insights into the underlying mechanisms linking MAM, nutritional recovery and microbiota composition. This study received approval from the National Ethic Committees of the four host countries as well as from the Internal Review Board of the Pasteur Institute in Paris.</p>
<sec id="Sec28">
<title>Trial status</title>
<p id="Par83">ClinicalTrials.gov, ID: NCT03474276 Last update on 28 May 2018.</p>
</sec>
</sec>
<sec sec-type="supplementary-material">
<title>Additional file</title>
<sec id="Sec29">
<p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="13063_2018_3027_MOESM1_ESM.doc"><label>Additional file 1:</label><caption><p>Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) 2013 Checklist: recommended items to address in a clinical trial protocol and related documents*. (DOC 122 kb)</p></caption></media></supplementary-material>
</p>
</sec>
</sec>
</body>
<back>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>ACF</term>
<def>
<p id="Par5">
<italic>Action Contre la Faim</italic>
</p>
</def>
</def-item>
<def-item>
<term>CAR</term>
<def>
<p id="Par6">Central African Republic</p>
</def>
</def-item>
<def-item>
<term>CM</term>
<def>
<p id="Par7">Chronic malnutrition</p>
</def>
</def-item>
<def-item>
<term>CRENAM</term>
<def>
<p id="Par8">
<italic>Centre de RENutrion re-Adaptation des Malnutris</italic>
</p>
</def>
</def-item>
<def-item>
<term>DMC II</term>
<def>
<p id="Par9">Developmental Milestones Checklist II</p>
</def>
</def-item>
<def-item>
<term>FOS</term>
<def>
<p id="Par10">Fructo-oligosaccharides</p>
</def>
</def-item>
<def-item>
<term>GAM</term>
<def>
<p id="Par11">Global acute malnutrition</p>
</def>
</def-item>
<def-item>
<term>GOS</term>
<def>
<p id="Par12">Galacto-oligosaccharides</p>
</def>
</def-item>
<def-item>
<term>MALINEA</term>
<def>
<p id="Par13">
<italic>Malnutrition et Infection de l’Enfance en Afrique</italic>
</p>
</def>
</def-item>
<def-item>
<term>MAM</term>
<def>
<p id="Par14">Moderate acute malnutrition</p>
</def>
</def-item>
<def-item>
<term>MUAC</term>
<def>
<p id="Par15">Mid-upper-arm circumference</p>
</def>
</def-item>
<def-item>
<term>NGO</term>
<def>
<p id="Par16">Nongovernmental organization</p>
</def>
</def-item>
<def-item>
<term>OTU</term>
<def>
<p id="Par17">Operational Taxonomic Unit</p>
</def>
</def-item>
<def-item>
<term>PEC-MAM</term>
<def>
<p id="Par18"><italic>Prise en Charge de la</italic> MAM</p>
</def>
</def-item>
<def-item>
<term>Q-PCR</term>
<def>
<p id="Par19">Quantitative polymerase chain reaction</p>
</def>
</def-item>
<def-item>
<term>SAM</term>
<def>
<p id="Par20">Severe acute malnutrition</p>
</def>
</def-item>
<def-item>
<term>SD</term>
<def>
<p id="Par21">Standard deviation</p>
</def>
</def-item>
<def-item>
<term>WHZ</term>
<def>
<p id="Par22">Weight-for-height Z-score</p>
</def>
</def-item>
</def-list>
</glossary>
<ack>
<title>Acknowledgements</title>
<p>The authors thank all the local staff involved in the registration of the children, the medical staff of the Health Ministry and the colleagues of the four French Embassies supporting the project. This is a collaborative project named MALINEA for <italic>“MAlnutrition et INfection de l’ENfance en Afrique”.</italic></p>
<sec id="FPar1">
<title>Funding</title>
<p id="Par84">The MALINEA project is funded by a grant from the French Foreign Office (MEAE 27 rue de la Convention 75732 Paris Cedex 15) through a <italic>Fond de Solidarité Prioritaire</italic> (<italic>FSP</italic>) n° 2101375618 (3 November 2014) and a grant from the Action against Hunger international foundation.</p>
</sec>
<sec id="FPar2">
<title>Availability of data and materials</title>
<p id="Par85">Data sharing is not applicable to this article, as no datasets were generated or analyzed at this stage of the current study. The datasets generated and/or analyzed during the trial will not be publicly available due to confidentiality but will be available from the corresponding author on reasonable request.</p>
</sec>
</ack>
<notes notes-type="author-contribution">
<title>Authors’ contributions</title>
<p>MV, BGH, PA, and CVP wrote the protocol. LT prepared the databases. AM, RR, and HM gave details on local epidemiology and organized the project in details on the field; AB, MA, and RJ gave expert advice on the choice of intervention. RJ coordinated the whole MALINEA project. All authors read and approved the final manuscript.</p>
</notes>
<notes notes-type="COI-statement">
<sec id="FPar3">
<title>Ethics approval and consent to participate</title>
<p>This study was conducted according to the protocol and ethical principles with their origins in the Declaration of Helsinki. The research protocol was approved by (1) the FDA-approved IRB (Institutional Review Board) and the CoRC (Clinical Research Committee) of Institut Pasteur, (2) the National Ethics Committee of the four countries, and (3) the CCTIRS (<italic>Comité Consultatif sur le Traitement de l’Information en matière de Recherche dans le domaine de la santé</italic>) and the CNIL (<italic>Commission Nationale de l’Information et des Libertés</italic>) in France. Written informed consent will be obtained from all children’s parents or legal guardians for both MAM and well-nourished children. The project will provide treatment and laboratory testing free of charge. An international insurance contract is already granted to cover all specific risk of the trial.</p>
</sec>
<sec id="FPar4">
<title>Consent for publication</title>
<p>Not applicable.</p>
</sec>
<sec id="FPar5">
<title>Competing interests</title>
<p>The authors declare that they have no competing interests. The funders had no role in the design of the protocol.</p>
</sec>
<sec id="FPar6">
<title>Publisher’s Note</title>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</sec>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anuradha</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Munisankar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bhootra</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>NP</given-names>
</name>
<name>
<surname>Dolla</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kumaran</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Babu</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Coexistent malnutrition is associated with perturbations in systemic and antigen-specific cytokine responses in latent tuberculosis infection</article-title>
<source/>Clin Vaccine Immunol
          <year>2016</year>
<volume>23</volume>
<fpage>339</fpage>
<lpage>345</lpage>
<pub-id pub-id-type="doi">10.1128/CVI.00009-16</pub-id>
<pub-id pub-id-type="pmid">26865593</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<mixed-citation publication-type="other">Crane RJ, Jones KDJ, Berkley JA. Environmental enteric dysfunction an overview. CMAM FORUM Technical Brief. 2014.</mixed-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gaayeb</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Pinçon</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Cames</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Sarr</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Seck</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Schacht</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Remoué</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Hermann</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Riveau</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Immune response to <italic>Bordetella pertussis</italic> is associated with season and undernutrition in Senegalese children</article-title>
<source/>Vaccine
          <year>2014</year>
<volume>32</volume>
<fpage>3431</fpage>
<lpage>3437</lpage>
<pub-id pub-id-type="doi">10.1016/j.vaccine.2014.03.086</pub-id>
<pub-id pub-id-type="pmid">24726248</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<collab>Anonymous</collab>
</person-group>
<source/>Enquête nationale sur le suivi des indicateurs des objectifs du Millénaire pour le développement durable 2012-2013
          <year>2014</year>
<publisher-loc>Madagascar</publisher-loc>
<publisher-name>INSTAT</publisher-name>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Briend</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Prinzo</surname>
<given-names>ZW</given-names>
</name>
</person-group>
<article-title>Dietary management of moderate malnutrition: time for a change</article-title>
<source/>Food Nutr Bull
          <year>2009</year>
<volume>30</volume>
<fpage>S265</fpage>
<lpage>S266</lpage>
<pub-id pub-id-type="doi">10.1177/15648265090303S301</pub-id>
<pub-id pub-id-type="pmid">19998862</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lazzerini</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rubert</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Pani</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Specially formulated foods for treating children with moderate acute malnutrition in low- and middle-income countries</article-title>
<source/>Cochrane Database Syst Rev
          <year>2013</year>
<volume>6</volume>
<fpage>CD009584</fpage>
<pub-id pub-id-type="doi">10.1002/14651858.CD009584.pub2</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lenters</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Wazny</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Webb</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ahmed</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Bhutta</surname>
<given-names>ZA</given-names>
</name>
</person-group>
<article-title>Treatment of severe and moderate acute malnutrition in low- and middle-income settings: a systematic review, meta-analysis and Delphi process</article-title>
<source/>BMC Public Health
          <year>2013</year>
<volume>13</volume>
<fpage>S23</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2458-13-S3-S23</pub-id>
<pub-id pub-id-type="pmid">24564235</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<mixed-citation publication-type="other">Navarro-colorado C, Mason F, Shoham J. Network paper measuring the effectiveness of supplementary feeding programmes in emergencies. Humanit Pract Netw. 2008;44.</mixed-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<mixed-citation publication-type="other">WHO. World Health Statistics. Geneva; 2017. <ext-link ext-link-type="uri" xlink:href="http://www.who.int/news-room/fact-sheets/detail/diarrhoeal-disease">http://www.who.int/news-room/fact-sheets/detail/diarrhoeal-disease</ext-link>. Accessed Nov 2018.</mixed-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<mixed-citation publication-type="other">UNICEF Data March 2018. <ext-link ext-link-type="uri" xlink:href="https://data.unicef.org/wp-content/uploads/2018/02/CoD_Diarrhoea_Feb-2018_WHO_MCEE_234.xlsx">https://data.unicef.org/wp-content/uploads/2018/02/CoD_Diarrhoea_Feb-2018_WHO_MCEE_234.xlsx</ext-link>. Accessed Nov 2018.</mixed-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>The</surname>
<given-names>Hao Chung</given-names>
</name>
<name>
<surname>Florez de Sessions</surname>
<given-names>Paola</given-names>
</name>
<name>
<surname>Jie</surname>
<given-names>Song</given-names>
</name>
<name>
<surname>Pham Thanh</surname>
<given-names>Duy</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>Corinne N.</given-names>
</name>
<name>
<surname>Nguyen Ngoc Minh</surname>
<given-names>Chau</given-names>
</name>
<name>
<surname>Chu</surname>
<given-names>Collins Wenhan</given-names>
</name>
<name>
<surname>Tran</surname>
<given-names>Tuan-Anh</given-names>
</name>
<name>
<surname>Thomson</surname>
<given-names>Nicholas R.</given-names>
</name>
<name>
<surname>Thwaites</surname>
<given-names>Guy E.</given-names>
</name>
<name>
<surname>Rabaa</surname>
<given-names>Maia A.</given-names>
</name>
<name>
<surname>Hibberd</surname>
<given-names>Martin</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>Stephen</given-names>
</name>
</person-group>
<article-title>Assessing gut microbiota perturbations during the early phase of infectious diarrhea in Vietnamese children</article-title>
<source/>Gut Microbes
          <year>2017</year>
<volume>9</volume>
<issue>1</issue>
<fpage>38</fpage>
<lpage>54</lpage>
<pub-id pub-id-type="doi">10.1080/19490976.2017.1361093</pub-id>
<pub-id pub-id-type="pmid">28767339</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prendergast</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Kelly</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Interactions between intestinal pathogens, enteropathy and malnutrition in developing countries</article-title>
<source/>Curr Opin Infect Dis
          <year>2016</year>
<volume>29</volume>
<fpage>229</fpage>
<lpage>236</lpage>
<pub-id pub-id-type="doi">10.1097/QCO.0000000000000261</pub-id>
<pub-id pub-id-type="pmid">26967147</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stiemsma</surname>
<given-names>LT</given-names>
</name>
<name>
<surname>Michels</surname>
<given-names>KB</given-names>
</name>
</person-group>
<article-title>The role of the microbiome in the developmental origins of health and disease</article-title>
<source/>Pediatrics
          <year>2018</year>
<volume>141</volume>
<fpage>e20172437</fpage>
<pub-id pub-id-type="doi">10.1542/peds.2017-2437</pub-id>
<pub-id pub-id-type="pmid">29519955</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laursen</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Bahl</surname>
<given-names>MI</given-names>
</name>
<name>
<surname>Michaelsen</surname>
<given-names>KF</given-names>
</name>
<name>
<surname>Licht</surname>
<given-names>TR</given-names>
</name>
</person-group>
<article-title>First foods and gut microbes</article-title>
<source/>Front Microbiol
          <year>2017</year>
<volume>8</volume>
<fpage>356</fpage>
<pub-id pub-id-type="doi">10.3389/fmicb.2017.00356</pub-id>
<pub-id pub-id-type="pmid">28321211</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Filippo</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Cavalieri</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Di Paola</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ramazzotti</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Poullet</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Massart</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa</article-title>
<source/>PNAS
          <year>2010</year>
<volume>107</volume>
<fpage>14691</fpage>
<lpage>14696</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1005963107</pub-id>
<pub-id pub-id-type="pmid">20679230</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grześkowiak</surname>
<given-names>Ł</given-names>
</name>
<name>
<surname>Collado</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Mangani</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Maleta</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Laitinen</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ashorn</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Distinct gut microbiota in Southeastern African and Northern European infants</article-title>
<source/>J Pediatr Gastroenterol Nutr
          <year>2012</year>
<volume>54</volume>
<fpage>812</fpage>
<lpage>816</lpage>
<pub-id pub-id-type="doi">10.1097/MPG.0b013e318249039c</pub-id>
<pub-id pub-id-type="pmid">22228076</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yatsunenko</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Rey</surname>
<given-names>FE</given-names>
</name>
<name>
<surname>Manary</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Trehan</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Dominguez-Bello</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Contreras</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Human gut microbiome viewed across age and geography</article-title>
<source/>Nature
          <year>2012</year>
<volume>486</volume>
<fpage>222</fpage>
<lpage>227</lpage>
<pub-id pub-id-type="doi">10.1038/nature11053</pub-id>
<pub-id pub-id-type="pmid">22699611</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghosh</surname>
<given-names>TS</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Bhattacharya</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Yadav</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Barik</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Chowdhury</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut microbiomes of Indian children of varying nutritional status</article-title>
<source/>PLoS One
          <year>2014</year>
<volume>9</volume>
<fpage>e95547</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0095547</pub-id>
<pub-id pub-id-type="pmid">24763225</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kane</surname>
<given-names>AV</given-names>
</name>
<name>
<surname>Dinh</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Ward</surname>
<given-names>HD</given-names>
</name>
</person-group>
<article-title>Childhood malnutrition and the intestinal microbiome</article-title>
<source/>Pediatr Res
          <year>2015</year>
<volume>77</volume>
<fpage>256</fpage>
<lpage>262</lpage>
<pub-id pub-id-type="doi">10.1038/pr.2014.179</pub-id>
<pub-id pub-id-type="pmid">25356748</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Million</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tidjani Alou</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Khelaifia</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bachar</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lagier</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Dione</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Increased gut redox and depletion of anaerobic and methanogenic prokaryotes in severe acute malnutrition</article-title>
<source/>Sci Rep
          <year>2016</year>
<volume>6</volume>
<fpage>26051</fpage>
<pub-id pub-id-type="doi">10.1038/srep26051</pub-id>
<pub-id pub-id-type="pmid">27183876</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Monira</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gotoh</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Izutsu</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Alam</surname>
<given-names>NH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut microbiota of healthy and malnourished children in Bangladesh</article-title>
<source/>Front Microbiol
          <year>2011</year>
<volume>2</volume>
<fpage>228</fpage>
<pub-id pub-id-type="doi">10.3389/fmicb.2011.00228</pub-id>
<pub-id pub-id-type="pmid">22125551</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>MI</given-names>
</name>
<name>
<surname>Yatsunenko</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Manary</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Trehan</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Mkakosya</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut microbiomes of Malawian twin pairs discordant for kwashiorkor</article-title>
<source/>Science
          <year>2013</year>
<volume>339</volume>
<fpage>548</fpage>
<lpage>554</lpage>
<pub-id pub-id-type="doi">10.1126/science.1229000</pub-id>
<pub-id pub-id-type="pmid">23363771</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Subramanian</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Huq</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yatsunenko</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Haque</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Mahfuz</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Alam</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Persistent gut microbiota immaturity in malnourished Bangladeshi children</article-title>
<source/>Nature
          <year>2014</year>
<volume>510</volume>
<fpage>417</fpage>
<lpage>421</lpage>
<pub-id pub-id-type="doi">10.1038/nature13421</pub-id>
<pub-id pub-id-type="pmid">24896187</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Velly</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Britton</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Preidis</surname>
<given-names>GA</given-names>
</name>
</person-group>
<article-title>Mechanisms of cross-talk between the diet, the intestinal microbiome, and the undernourished host</article-title>
<source/>Gut Microbes
          <year>2017</year>
<volume>8</volume>
<fpage>98</fpage>
<lpage>112</lpage>
<pub-id pub-id-type="doi">10.1080/19490976.2016.1267888</pub-id>
<pub-id pub-id-type="pmid">27918230</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jain</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>WA</given-names>
</name>
</person-group>
<article-title>Diet and host-microbial crosstalk in postnatal intestinal immune homeostasis</article-title>
<source/>Nat Rev Gastroenterol Hepatol
          <year>2015</year>
<volume>12</volume>
<fpage>14</fpage>
<lpage>25</lpage>
<pub-id pub-id-type="doi">10.1038/nrgastro.2014.153</pub-id>
<pub-id pub-id-type="pmid">25201040</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silva</surname>
<given-names>Marcelo José Barbosa</given-names>
</name>
<name>
<surname>Carneiro</surname>
<given-names>Matheus Batista Heitor</given-names>
</name>
<name>
<surname>dos Anjos Pultz</surname>
<given-names>Brunna</given-names>
</name>
<name>
<surname>Pereira Silva</surname>
<given-names>Danielle</given-names>
</name>
<name>
<surname>Lopes</surname>
<given-names>Mateus Eustáquio de Moura</given-names>
</name>
<name>
<surname>dos Santos</surname>
<given-names>Liliane Martins</given-names>
</name>
</person-group>
<article-title>The Multifaceted Role of Commensal Microbiota in Homeostasis and Gastrointestinal Diseases</article-title>
<source/>Journal of Immunology Research
          <year>2015</year>
<volume>2015</volume>
<fpage>1</fpage>
<lpage>14</lpage>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Britton</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>VB</given-names>
</name>
</person-group>
<article-title>Role of the intestinal microbiota in resistance to colonization by <italic>Clostridium difficile</italic></article-title>
<source/>Gastroenterology
          <year>2014</year>
<volume>146</volume>
<fpage>1547</fpage>
<lpage>1553</lpage>
<pub-id pub-id-type="doi">10.1053/j.gastro.2014.01.059</pub-id>
<pub-id pub-id-type="pmid">24503131</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<mixed-citation publication-type="other">Stecher B. The roles of inflammation, nutrient availability and the commensal microbiota in enteric pathogen infection. Microbiol Spectr. 2015;3(3). 10.1128/microbiolspec.MBP-0008-2014.</mixed-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kostic</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Xavier</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Gevers</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>The microbiome in inflammatory bowel disease: current status and the future ahead</article-title>
<source/>Gastroenterology
          <year>2014</year>
<volume>146</volume>
<fpage>1489</fpage>
<lpage>1499</lpage>
<pub-id pub-id-type="doi">10.1053/j.gastro.2014.02.009</pub-id>
<pub-id pub-id-type="pmid">24560869</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manichanh</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Borruel</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Casellas</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Guarner</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>The gut microbiota in IBD</article-title>
<source/>Nat Rev Gastroenterol Hepatol
          <year>2012</year>
<volume>9</volume>
<fpage>599</fpage>
<lpage>608</lpage>
<pub-id pub-id-type="doi">10.1038/nrgastro.2012.152</pub-id>
<pub-id pub-id-type="pmid">22907164</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marasco</surname>
<given-names>Giovanni</given-names>
</name>
<name>
<surname>Di Biase</surname>
<given-names>Anna Rita</given-names>
</name>
<name>
<surname>Schiumerini</surname>
<given-names>Ramona</given-names>
</name>
<name>
<surname>Eusebi</surname>
<given-names>Leonardo Henry</given-names>
</name>
<name>
<surname>Iughetti</surname>
<given-names>Lorenzo</given-names>
</name>
<name>
<surname>Ravaioli</surname>
<given-names>Federico</given-names>
</name>
<name>
<surname>Scaioli</surname>
<given-names>Eleonora</given-names>
</name>
<name>
<surname>Colecchia</surname>
<given-names>Antonio</given-names>
</name>
<name>
<surname>Festi</surname>
<given-names>Davide</given-names>
</name>
</person-group>
<article-title>Gut Microbiota and Celiac Disease</article-title>
<source/>Digestive Diseases and Sciences
          <year>2016</year>
<volume>61</volume>
<issue>6</issue>
<fpage>1461</fpage>
<lpage>1472</lpage>
<pub-id pub-id-type="doi">10.1007/s10620-015-4020-2</pub-id>
<pub-id pub-id-type="pmid">26725064</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bohm</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Siwiec</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Wo</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>Diagnosis and management of small intestinal bacterial overgrowth</article-title>
<source/>Nutr Clin Pract
          <year>2013</year>
<volume>28</volume>
<fpage>289</fpage>
<lpage>299</lpage>
<pub-id pub-id-type="doi">10.1177/0884533613485882</pub-id>
<pub-id pub-id-type="pmid">23614961</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hughes</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Zola</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Penttila</surname>
<given-names>IA</given-names>
</name>
<name>
<surname>Blackshaw</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Andrews</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Krumbiegel</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Immune activation in irritable bowel syndrome: can neuroimmune interactions explain symptoms?</article-title>
<source/>Am J Gastroenterol
          <year>2013</year>
<volume>108</volume>
<fpage>1066</fpage>
<lpage>1074</lpage>
<pub-id pub-id-type="doi">10.1038/ajg.2013.120</pub-id>
<pub-id pub-id-type="pmid">23649183</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Di Mauro</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Neu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Riezzo</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Raimondi</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Martinelli</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Francavilla</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Indrio</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Gastrointestinal function development and microbiota</article-title>
<source/>Ital J Pediatr
          <year>2013</year>
<volume>24</volume>
<fpage>15</fpage>
<pub-id pub-id-type="doi">10.1186/1824-7288-39-15</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Atarashi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tanoue</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Oshima</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Suda</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Nagano</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Nishikawa</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Fukuda</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Saito</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Narushima</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hase</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Fritz</surname>
<given-names>JV</given-names>
</name>
<name>
<surname>Wilmes</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ueha</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Matsushima</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ohno</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Olle</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Sakaguchi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Taniguchi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Morita</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hattori</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Honda</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota</article-title>
<source/>Nature
          <year>2013</year>
<volume>500</volume>
<fpage>232</fpage>
<lpage>236</lpage>
<pub-id pub-id-type="doi">10.1038/nature12331</pub-id>
<pub-id pub-id-type="pmid">23842501</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schwabe</surname>
<given-names>RF</given-names>
</name>
<name>
<surname>Jobin</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>The microbiome and cancer</article-title>
<source/>Nat Rev Cancer
          <year>2013</year>
<volume>13</volume>
<fpage>800</fpage>
<lpage>812</lpage>
<pub-id pub-id-type="doi">10.1038/nrc3610</pub-id>
<pub-id pub-id-type="pmid">24132111</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stringer</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Al-Dasooqi</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Bowen</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Radzuan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Logan</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Mayo</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Keefe</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Gibson</surname>
<given-names>RJ</given-names>
</name>
</person-group>
<article-title>Biomarkers of chemotherapy-induced diarrhoea: a clinical study of intestinal microbiome alterations, inflammation and circulating matrix metalloproteinases</article-title>
<source/>Support Care Cancer
          <year>2013</year>
<volume>21</volume>
<fpage>1843</fpage>
<lpage>1852</lpage>
<pub-id pub-id-type="doi">10.1007/s00520-013-1741-7</pub-id>
<pub-id pub-id-type="pmid">23397098</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>The gut microbiota and obesity: from correlation to causality</article-title>
<source/>Nat Rev Microbiol
          <year>2013</year>
<volume>11</volume>
<fpage>639</fpage>
<lpage>647</lpage>
<pub-id pub-id-type="doi">10.1038/nrmicro3089</pub-id>
<pub-id pub-id-type="pmid">23912213</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khan</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Nieuwdorp</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bäckhed</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Microbial modulation of insulin sensitivity</article-title>
<source/>Cell Metab
          <year>2014</year>
<volume>20</volume>
<fpage>753</fpage>
<lpage>760</lpage>
<pub-id pub-id-type="doi">10.1016/j.cmet.2014.07.006</pub-id>
<pub-id pub-id-type="pmid">25176147</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dinh</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Ramadass</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Kattula</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Sarkar</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Braunstein</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Tai</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Longitudinal analysis of the intestinal microbiota in persistently stunted young children in South India</article-title>
<source/>PLoS One
          <year>2016</year>
<volume>11</volume>
<fpage>e0155405</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0155405</pub-id>
<pub-id pub-id-type="pmid">27228122</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bartelt</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Bolick</surname>
<given-names>DT</given-names>
</name>
<name>
<surname>Mayneris-Perxachs</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kolling</surname>
<given-names>GL</given-names>
</name>
<name>
<surname>Medlock</surname>
<given-names>GL</given-names>
</name>
<name>
<surname>Zaenker</surname>
<given-names>EI</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cross-modulation of pathogen-specific pathways enhances malnutrition during enteric co-infection with <italic>Giardia lamblia</italic> and enteroaggregative <italic>Escherichia coli</italic></article-title>
<source/>PLoS Pathog
          <year>2017</year>
<volume>13</volume>
<fpage>e1006471</fpage>
<pub-id pub-id-type="doi">10.1371/journal.ppat.1006471</pub-id>
<pub-id pub-id-type="pmid">28750066</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moloney</surname>
<given-names>Rachel D.</given-names>
</name>
<name>
<surname>Desbonnet</surname>
<given-names>Lieve</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>Gerard</given-names>
</name>
<name>
<surname>Dinan</surname>
<given-names>Timothy G.</given-names>
</name>
<name>
<surname>Cryan</surname>
<given-names>John F.</given-names>
</name>
</person-group>
<article-title>The microbiome: stress, health and disease</article-title>
<source/>Mammalian Genome
          <year>2013</year>
<volume>25</volume>
<issue>1-2</issue>
<fpage>49</fpage>
<lpage>74</lpage>
<pub-id pub-id-type="doi">10.1007/s00335-013-9488-5</pub-id>
<pub-id pub-id-type="pmid">24281320</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lyte</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Microbial endocrinology in the microbiome-gut-brain axis: how bacterial production and utilization of neurochemicals influence behavior</article-title>
<source/>PLoS Pathog
          <year>2013</year>
<volume>9</volume>
<fpage>11</fpage>
<pub-id pub-id-type="doi">10.1371/journal.ppat.1003726</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qureshi</surname>
<given-names>IA</given-names>
</name>
<name>
<surname>Mehler</surname>
<given-names>MF</given-names>
</name>
</person-group>
<article-title>Towards a “systems”-level understanding of the nervous system and its disorders</article-title>
<source/>Trends Neurosci
          <year>2013</year>
<volume>36</volume>
<fpage>674</fpage>
<lpage>684</lpage>
<pub-id pub-id-type="doi">10.1016/j.tins.2013.07.003</pub-id>
<pub-id pub-id-type="pmid">23988221</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Collins</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Kassam</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Bercik</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>The adoptive transfer of behavioral phenotype via the intestinal microbiota: experimental evidence and clinical implications</article-title>
<source/>Curr Opin Microbiol
          <year>2013</year>
<volume>16</volume>
<fpage>240</fpage>
<lpage>245</lpage>
<pub-id pub-id-type="doi">10.1016/j.mib.2013.06.004</pub-id>
<pub-id pub-id-type="pmid">23845749</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hornig</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>The role of microbes and autoimmunity in the pathogenesis of neuropsychiatric illness</article-title>
<source/>Curr Opin Rheumatol
          <year>2013</year>
<volume>25</volume>
<fpage>488</fpage>
<lpage>795</lpage>
<pub-id pub-id-type="doi">10.1097/BOR.0b013e32836208de</pub-id>
<pub-id pub-id-type="pmid">23656715</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Christie</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Heikens</surname>
<given-names>GT</given-names>
</name>
<name>
<surname>McFarlane</surname>
<given-names>DE</given-names>
</name>
</person-group>
<article-title>Nosocomial and community-acquired infections in malnourished children</article-title>
<source/>J Trop Med Hyg
          <year>1988</year>
<volume>91</volume>
<fpage>173</fpage>
<lpage>180</lpage>
<pub-id pub-id-type="pmid">3404564</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Macdougall</surname>
<given-names>LG</given-names>
</name>
</person-group>
<article-title>The effect of aureomycin in undernourished African children</article-title>
<source/>J Trop Pediatr
          <year>1957</year>
<volume>3</volume>
<fpage>74</fpage>
<lpage>81</lpage>
<pub-id pub-id-type="doi">10.1093/oxfordjournals.tropej.a057461</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trehan</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Shulman</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Ou</surname>
<given-names>CN</given-names>
</name>
<name>
<surname>Maleta</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Manary</surname>
<given-names>MJ</given-names>
</name>
</person-group>
<article-title>A randomized, double-blind, placebo-controlled trial of rifaximin, a nonabsorbable antibiotic, in the treatment of tropical enteropathy</article-title>
<source/>Am J Gastroenterol
          <year>2009</year>
<volume>104</volume>
<fpage>2326</fpage>
<lpage>2333</lpage>
<pub-id pub-id-type="doi">10.1038/ajg.2009.270</pub-id>
<pub-id pub-id-type="pmid">19491826</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trehan</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Goldbach</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>LaGrone</surname>
<given-names>LN</given-names>
</name>
<name>
<surname>Meuli</surname>
<given-names>GJ</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Maleta</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Manary</surname>
<given-names>MJ</given-names>
</name>
</person-group>
<article-title>Antibiotics as part of the management of severe acute malnutrition</article-title>
<source/>N Engl J Med
          <year>2013</year>
<volume>368</volume>
<fpage>425</fpage>
<lpage>435</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMoa1202851</pub-id>
<pub-id pub-id-type="pmid">23363496</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Isanaka</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Langendorf</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Berthé</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Gnegne</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ousmane</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Harouna</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hassane</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Schaefer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Adehossi</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Grais</surname>
<given-names>RF</given-names>
</name>
</person-group>
<article-title>Routine amoxicillin for uncomplicated severe acute malnutrition in children</article-title>
<source/>N Engl J Med
          <year>2016</year>
<volume>374</volume>
<fpage>444</fpage>
<lpage>453</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMoa1507024</pub-id>
<pub-id pub-id-type="pmid">26840134</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berkley</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Ngari</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Thitiri</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mwalekwa</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Timbwa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hamid</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Ali</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Shangala</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mturi</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>KDJ</given-names>
</name>
<name>
<surname>Alphan</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Mutai</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Bandika</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Hemed</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Awuondo</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Morpeth</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kariuki</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Fegan</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Daily co-trimoxazole prophylaxis to prevent mortality in children with complicated severe acute malnutrition: a multicentre, double-blind, randomised placebo-controlled trial</article-title>
<source/>Lancet Glob Health
          <year>2016</year>
<volume>4</volume>
<fpage>e464</fpage>
<lpage>e473</lpage>
<pub-id pub-id-type="doi">10.1016/S2214-109X(16)30096-1</pub-id>
<pub-id pub-id-type="pmid">27265353</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lazzerini</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tickell</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Antibiotics in severely malnourished children: systematic review of efficacy, safety and pharmacokinetics</article-title>
<source/>Bull World Health Organ
          <year>2011</year>
<volume>89</volume>
<issue>8</issue>
<fpage>594</fpage>
<lpage>607</lpage>
<pub-id pub-id-type="doi">10.2471/BLT.10.084715</pub-id>
<pub-id pub-id-type="pmid">21836758</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shirajum</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shota</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kazuyoshi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Kaori</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Alam</surname>
<given-names>NH</given-names>
</name>
<name>
<surname>Nakaya</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Horii</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ali</surname>
<given-names>SI</given-names>
</name>
<name>
<surname>Iida</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Alam</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Metagenomic profile of gut microbiota in children during cholera and recovery</article-title>
<source/>Gut Pathogens
          <year>2013</year>
<volume>5</volume>
<fpage>1</fpage>
<pub-id pub-id-type="doi">10.1186/1757-4749-5-1</pub-id>
<pub-id pub-id-type="pmid">23369162</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Isanaka</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Adehoss</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Grais</surname>
<given-names>RF</given-names>
</name>
</person-group>
<article-title>Amoxicillin for severe acute malnutrition in children</article-title>
<source/>N Engl J Med
          <year>2016</year>
<volume>375</volume>
<fpage>191</fpage>
<lpage>192</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMc1605388</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Million</surname>
<given-names>Matthieu</given-names>
</name>
<name>
<surname>Lagier</surname>
<given-names>Jean-Christophe</given-names>
</name>
<name>
<surname>Raoult</surname>
<given-names>Didier</given-names>
</name>
</person-group>
<article-title>Meta-analysis on efficacy of amoxicillin in uncomplicated severe acute malnutrition</article-title>
<source/>Microbial Pathogenesis
          <year>2017</year>
<volume>106</volume>
<fpage>76</fpage>
<lpage>77</lpage>
<pub-id pub-id-type="doi">10.1016/j.micpath.2016.06.025</pub-id>
<pub-id pub-id-type="pmid">27374892</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okeke</surname>
<given-names>IN</given-names>
</name>
<name>
<surname>Cruz</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Keusch</surname>
<given-names>GT</given-names>
</name>
<collab>and Alliance for the Prudent Use of Antibiotics–Nutrition Group</collab>
</person-group>
<article-title>Antibiotics for uncomplicated severe malnutrition</article-title>
<source/>N Engl J Med
          <year>2013</year>
<volume>368</volume>
<fpage>2435</fpage>
<lpage>2436</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMc1304407#SA2</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rawson</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>Holmes</surname>
<given-names>AH</given-names>
</name>
</person-group>
<article-title>Amoxicillin for severe acute malnutrition in children</article-title>
<source/>N Engl J Med
          <year>2016</year>
<volume>375</volume>
<fpage>190</fpage>
<lpage>191</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMc1605388#SA1</pub-id>
<pub-id pub-id-type="pmid">27410939</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trehan</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Schechtman</surname>
<given-names>KB</given-names>
</name>
<name>
<surname>Manary</surname>
<given-names>MJ</given-names>
</name>
</person-group>
<article-title>Amoxicillin for severe acute malnutrition in children</article-title>
<source/>N Engl J Med
          <year>2016</year>
<volume>375</volume>
<fpage>191</fpage>
<pub-id pub-id-type="doi">10.1056/NEJMc1605388#SA2</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<label>60.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Williams</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Berkley</surname>
<given-names>JA</given-names>
</name>
</person-group>
<source/>Severe acute malnutrition update: current WHO guidelines and WHO essential medicine list for children
          <year>2016</year>
</element-citation>
</ref>
<ref id="CR61">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Drissi</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Buffet</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Raoult</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Merhej</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Common occurrence of antibacterial agents in human intestinal microbiota</article-title>
<source/>Front Microbiol
          <year>2015</year>
<volume>6</volume>
<fpage>441</fpage>
<pub-id pub-id-type="doi">10.3389/fmicb.2015.00441</pub-id>
<pub-id pub-id-type="pmid">25999943</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Langdon</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Crook</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Dantas</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation</article-title>
<source/>Genome Med
          <year>2016</year>
<volume>8</volume>
<fpage>39</fpage>
<pub-id pub-id-type="doi">10.1186/s13073-016-0294-z</pub-id>
<pub-id pub-id-type="pmid">27074706</pub-id>
</element-citation>
</ref>
<ref id="CR63">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luntamo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kulmala</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Cheung</surname>
<given-names>YB</given-names>
</name>
<name>
<surname>Maleta</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ashorn</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>The effect of antenatal monthly sulphadoxine-pyrimethamine, alone or with azithromycin, on foetal and neonatal growth faltering in Malawi: a randomised controlled trial</article-title>
<source/>Trop Med Int Health
          <year>2013</year>
<volume>18</volume>
<fpage>386</fpage>
<lpage>397</lpage>
<pub-id pub-id-type="doi">10.1111/tmi.12074</pub-id>
<pub-id pub-id-type="pmid">23432801</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Keenan</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Bailey</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>West</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Arzika</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Hart</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Weaver</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kalua</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Mrango</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Ray</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Cook</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lebas</surname>
<given-names>E</given-names>
</name>
<name>
<surname>O’Brien</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Emerson</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Porco</surname>
<given-names>NZ</given-names>
</name>
<collab>and Lietman TM for the MORDOR Study Group</collab>
</person-group>
<article-title>Azithromycin to reduce childhood mortality in Sub-Saharan Africa</article-title>
<source/>N Engl J Med
          <year>2018</year>
<volume>378</volume>
<fpage>1583</fpage>
<lpage>1592</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMoa1715474</pub-id>
<pub-id pub-id-type="pmid">29694816</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bisanz</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Enos</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>PrayGod</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Microbiota at multiple body sites during pregnancy in a rural Tanzanian population and effects of moringa-supplemented probiotic yogurt</article-title>
<source/>Appl Environ Microbiol
          <year>2015</year>
<volume>81</volume>
<fpage>4965</fpage>
<lpage>4975</lpage>
<pub-id pub-id-type="doi">10.1128/AEM.00780-15</pub-id>
<pub-id pub-id-type="pmid">25979893</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Charbonneau</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>O’Donnell</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Blanton</surname>
<given-names>LV</given-names>
</name>
</person-group>
<article-title>Sialylated milk oligosaccharides promote microbiota-dependent growth in models of infant undernutrition</article-title>
<source/>Cell
          <year>2016</year>
<volume>164</volume>
<fpage>859</fpage>
<lpage>871</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2016.01.024</pub-id>
<pub-id pub-id-type="pmid">26898329</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blanton</surname>
<given-names>LV</given-names>
</name>
<name>
<surname>Barratt</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Charbonneau</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Ahmed</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>JI</given-names>
</name>
</person-group>
<article-title>Childhood undernutrition, the gut microbiota, and microbiota-directed therapeutics</article-title>
<source/>Science
          <year>2016</year>
<volume>352</volume>
<fpage>1533</fpage>
<pub-id pub-id-type="doi">10.1126/science.aad9359</pub-id>
<pub-id pub-id-type="pmid">27339978</pub-id>
</element-citation>
</ref>
<ref id="CR68">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Angelakis</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Merhej</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Raoult</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Related actions of probiotics and antibiotics on gut microbiota and weight modification</article-title>
<source/>Lancet Inf Dis
          <year>2013</year>
<volume>13</volume>
<fpage>889</fpage>
<lpage>899</lpage>
<pub-id pub-id-type="doi">10.1016/S1473-3099(13)70179-8</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kerac</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bunn</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Seal</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Thindwa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tomkins</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sadler</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Bahwere</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double-blind efficacy randomised controlled trial in Malawi</article-title>
<source/>Lancet
          <year>2009</year>
<volume>374</volume>
<fpage>136</fpage>
<lpage>144</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(09)60884-9</pub-id>
<pub-id pub-id-type="pmid">19595348</pub-id>
</element-citation>
</ref>
<ref id="CR70">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Slattery</surname>
<given-names>DF</given-names>
</name>
<name>
<surname>MacFabe</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Frye</surname>
<given-names>RE</given-names>
</name>
</person-group>
<article-title>The Significance of the enteric microbiome on the development of childhood disease: a review of prebiotic and probiotic therapies in disorders of childhood</article-title>
<source/>Clin Med Ins Ped
          <year>2016</year>
<volume>10</volume>
<fpage>91</fpage>
<lpage>107</lpage>
</element-citation>
</ref>
<ref id="CR71">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Firmansyah</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Chongviriyaphan</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Dillon</surname>
<given-names>DHS</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>NC</given-names>
</name>
<name>
<surname>Morita</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Tontisirin</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tuyen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Bindels</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Deurenberg</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ong</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hautvast</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Vaughan</surname>
<given-names>EE</given-names>
</name>
</person-group>
<article-title>Fructans in the first 1000 days of life and beyond, and for pregnancy</article-title>
<source/>Asia Pac J Clin Nutr
          <year>2016</year>
<volume>25</volume>
<fpage>652</fpage>
<lpage>675</lpage>
<pub-id pub-id-type="pmid">27702710</pub-id>
</element-citation>
</ref>
<ref id="CR72">
<label>72.</label>
<mixed-citation publication-type="other">Franco-Robles E, López MG. Implication of fructans in health: immunomodulatory and antioxidant mechanisms. Sci World J. 2015:289267.</mixed-citation>
</ref>
<ref id="CR73">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kolida</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tuohy</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Gibson</surname>
<given-names>GR</given-names>
</name>
</person-group>
<article-title>Prebiotic effects of inulin and oligofructose</article-title>
<source/>Br J Nutr
          <year>2002</year>
<volume>87</volume>
<issue>Suppl 2</issue>
<fpage>S193</fpage>
<lpage>S197</lpage>
<pub-id pub-id-type="doi">10.1079/BJNBJN/2002537</pub-id>
<pub-id pub-id-type="pmid">12088518</pub-id>
</element-citation>
</ref>
<ref id="CR74">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roberfroid</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gibson</surname>
<given-names>GR</given-names>
</name>
<name>
<surname>Hoyles</surname>
<given-names>L</given-names>
</name>
<name>
<surname>McCartney</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Rastall</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Rowland</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prebiotic effects : metabolic and health benefits</article-title>
<source/>CentAUR
          <year>2010</year>
<volume>104</volume>
<fpage>S1</fpage>
<lpage>63</lpage>
<pub-id pub-id-type="doi">10.1017/S0007114510003363</pub-id>
</element-citation>
</ref>
<ref id="CR75">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dewulf</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Cani</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>Claus</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Fuentes</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Puylaert</surname>
<given-names>PGB</given-names>
</name>
<name>
<surname>Neyrinck</surname>
<given-names>AM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women</article-title>
<source/>Gut
          <year>2013</year>
<volume>62</volume>
<fpage>1112</fpage>
<lpage>1121</lpage>
<pub-id pub-id-type="doi">10.1136/gutjnl-2012-303304</pub-id>
<pub-id pub-id-type="pmid">23135760</pub-id>
</element-citation>
</ref>
<ref id="CR76">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Piemontese</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Giannı</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Braegger</surname>
<given-names>CP</given-names>
</name>
<name>
<surname>Chirico</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Gruber</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Tolerance and safety evaluation in a large cohort of healthy infants fed an innovative prebiotic formula: a randomized controlled trial</article-title>
<source/>PLoS ONE
          <year>2011</year>
<volume>6</volume>
<fpage>e28010</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0028010</pub-id>
<pub-id pub-id-type="pmid">22140499</pub-id>
</element-citation>
</ref>
<ref id="CR77">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gibson</surname>
<given-names>GR</given-names>
</name>
<name>
<surname>Beatty</surname>
<given-names>ER</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Cummings</surname>
<given-names>JH</given-names>
</name>
</person-group>
<article-title>Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin</article-title>
<source/>Gastroenterology
          <year>1995</year>
<volume>108</volume>
<fpage>975</fpage>
<lpage>982</lpage>
<pub-id pub-id-type="doi">10.1016/0016-5085(95)90192-2</pub-id>
<pub-id pub-id-type="pmid">7698613</pub-id>
</element-citation>
</ref>
<ref id="CR78">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meyer</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Stasse-Wolthuis</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>The bifidogenic effect of inulin and oligofructose and its consequences for gut health</article-title>
<source/>Eur J Clin Nutr
          <year>2009</year>
<volume>63</volume>
<fpage>1277</fpage>
<lpage>1289</lpage>
<pub-id pub-id-type="doi">10.1038/ejcn.2009.64</pub-id>
<pub-id pub-id-type="pmid">19690573</pub-id>
</element-citation>
</ref>
<ref id="CR79">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramirez-Farias</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Slezak</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Fuller</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Duncan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Holtrop</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Louis</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Effect of inulin on the human gut microbiota: stimulation of <italic>Bifidobacterium adolescentis</italic> and <italic>Faecalibacterium prausnitzii</italic></article-title>
<source/>Br J Nutr
          <year>2009</year>
<volume>101</volume>
<fpage>541</fpage>
<lpage>550</lpage>
<pub-id pub-id-type="doi">10.1017/S0007114508019880</pub-id>
<pub-id pub-id-type="pmid">18590586</pub-id>
</element-citation>
</ref>
<ref id="CR80">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chung</surname>
<given-names>WSF</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>AW</given-names>
</name>
<name>
<surname>Louis</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Parkhil</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Vermeiren</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bosscher</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Modulation of the human gut microbiota by dietary fibres occurs at the species level</article-title>
<source/>BMC Biol
          <year>2016</year>
<volume>14</volume>
<fpage>3</fpage>
<pub-id pub-id-type="doi">10.1186/s12915-015-0224-3</pub-id>
<pub-id pub-id-type="pmid">26754945</pub-id>
</element-citation>
</ref>
<ref id="CR81">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jung</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Jeon</surname>
<given-names>WM</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>KS</given-names>
</name>
</person-group>
<article-title>In vitro effects of dietary inulin on human fecal microbiota and butyrate production</article-title>
<source/>J Microbiol Biotechnol
          <year>2015</year>
<volume>25</volume>
<fpage>1555</fpage>
<lpage>1558</lpage>
<pub-id pub-id-type="doi">10.4014/jmb.1505.05078</pub-id>
<pub-id pub-id-type="pmid">26095388</pub-id>
</element-citation>
</ref>
<ref id="CR82">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Orel</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Kamhi Trop</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease</article-title>
<source/>World J Gastroenterol
          <year>2014</year>
<volume>20</volume>
<fpage>11505</fpage>
<lpage>11524</lpage>
<pub-id pub-id-type="doi">10.3748/wjg.v20.i33.11505</pub-id>
<pub-id pub-id-type="pmid">25206258</pub-id>
</element-citation>
</ref>
<ref id="CR83">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Steed</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Macfarlane</surname>
<given-names>GT</given-names>
</name>
<name>
<surname>Blackett</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Bahrami</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Reynolds</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Walsh</surname>
<given-names>SV</given-names>
</name>
<name>
<surname>Cummings</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Macfarlane</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Clinical trial: the microbiological and immunological effects of symbiotic consumption - a randomized double-blind placebo-controlled study in active Crohn’s disease</article-title>
<source/>Aliment Pharmacol Ther
          <year>2010</year>
<volume>32</volume>
<fpage>872</fpage>
<lpage>883</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2036.2010.04417.x</pub-id>
<pub-id pub-id-type="pmid">20735782</pub-id>
</element-citation>
</ref>
<ref id="CR84">
<label>84.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<collab>Anonymous</collab>
</person-group>
<source/>Key outcomes of the Technical Meeting on Environmental Enteric Dysfunction, the Microbiome Undernutrition
          <year>2015</year>
<publisher-loc>Vienna</publisher-loc>
<publisher-name>IAEA</publisher-name>
</element-citation>
</ref>
<ref id="CR85">
<label>85.</label>
<mixed-citation publication-type="other">Anonymous. World Gastroenterology Organisation. Practical recommandations: Probiotiques et Prébiotiques. Mai 2008</mixed-citation>
</ref>
<ref id="CR86">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rivera-Huerta</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lizárraga-Grimes</surname>
<given-names>VL</given-names>
</name>
<name>
<surname>Castro-Torres</surname>
<given-names>IG</given-names>
</name>
<name>
<surname>Tinoco-Méndez</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Macías-Rosales</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Sánchez-Bartéz</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Tapia-Pérez</surname>
<given-names>GG</given-names>
</name>
<name>
<surname>Romero-Romero</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gracia-Mora</surname>
<given-names>MI</given-names>
</name>
</person-group>
<article-title>Functional effects of prebiotic fructans in colon cancer and calcium metabolism in animal models</article-title>
<source/>Biomed Res Int
          <year>2017</year>
<volume>2017</volume>
<fpage>975</fpage>
<lpage>982</lpage>
<pub-id pub-id-type="doi">10.1155/2017/9758982</pub-id>
</element-citation>
</ref>
<ref id="CR87">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roberfroid</surname>
<given-names>MB</given-names>
</name>
</person-group>
<article-title>Inulin-type fructans: functional food ingredients</article-title>
<source/>J Nutr
          <year>2007</year>
<volume>137</volume>
<fpage>2493S</fpage>
<lpage>2502S</lpage>
<pub-id pub-id-type="doi">10.1093/jn/137.11.2493S</pub-id>
<pub-id pub-id-type="pmid">17951492</pub-id>
</element-citation>
</ref>
<ref id="CR88">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dehghan</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Farhangi</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Tavakoli</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Aliasgarzadeh</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Akbari</surname>
<given-names>AM</given-names>
</name>
</person-group>
<article-title>Impact of prebiotic supplementation on T-cell subsets and their related cytokines, anthropometric features and blood pressure in patients with type 2 diabetes mellitus: a randomized placebo-controlled Trial</article-title>
<source/>Complement Ther Med
          <year>2016</year>
<volume>24</volume>
<fpage>96</fpage>
<lpage>102</lpage>
<pub-id pub-id-type="doi">10.1016/j.ctim.2015.12.010</pub-id>
<pub-id pub-id-type="pmid">26860809</pub-id>
</element-citation>
</ref>
<ref id="CR89">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hanlon</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Compher</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Low blood zinc, iron, and other sociodemographic factors associated with behavior problems in preschoolers</article-title>
<source/>Nutrients
          <year>2014</year>
<volume>6</volume>
<fpage>530</fpage>
<lpage>545</lpage>
<pub-id pub-id-type="doi">10.3390/nu6020530</pub-id>
<pub-id pub-id-type="pmid">24473235</pub-id>
</element-citation>
</ref>
<ref id="CR90">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sandjaja</surname>
</name>
<name>
<surname>Poh</surname>
<given-names>BK</given-names>
</name>
<name>
<surname>Rojroonwasinkul</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Le Nyugen</surname>
<given-names>BK</given-names>
</name>
<name>
<surname>Budiman</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>LO</given-names>
</name>
<name>
<surname>Soonthorndhada</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Xuyen</surname>
<given-names>HT</given-names>
</name>
<name>
<surname>Deurenberg</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Parikh</surname>
<given-names>P</given-names>
</name>
<collab>SEANUTS Study Group</collab>
</person-group>
<article-title>Relationship between anthropometric indicators and cognitive performance in Southeast Asian school-aged children</article-title>
<source/>Br J Nutr
          <year>2013</year>
<volume>110</volume>
<fpage>S57</fpage>
<lpage>S64</lpage>
<pub-id pub-id-type="doi">10.1017/S0007114513002079.</pub-id>
<pub-id pub-id-type="pmid">24016767</pub-id>
</element-citation>
</ref>
<ref id="CR91">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goyala</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Venkateshb</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Milbrandt</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>JI</given-names>
</name>
<name>
<surname>Raichl</surname>
<given-names>ME</given-names>
</name>
</person-group>
<article-title>Feeding the brain and nurturing the mind: linking nutrition and the gut microbiota to brain development</article-title>
<source/>PNAS
          <year>2015</year>
<volume>112</volume>
<fpage>14105</fpage>
<lpage>14112</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1511465112</pub-id>
<pub-id pub-id-type="pmid">26578751</pub-id>
</element-citation>
</ref>
<ref id="CR92">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Madore</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Leyrolle</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Lacabanne</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Benmamar-Badel</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Joffre</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Nadjar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Layé</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Neuroinflammation in autism: plausible role of maternal inflammation, dietary omega 3, and microbiota</article-title>
<source/>Neural Plasticity
          <year>2016</year>
<volume>3597209</volume>
<fpage>15</fpage>
</element-citation>
</ref>
<ref id="CR93">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhoite</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Iyer</surname>
<given-names>UM</given-names>
</name>
</person-group>
<article-title>Effect of deworming vs Iron-Folic acid supplementation plus deworming on growth, hemoglobin level, and physical work capacity of schoolchildren</article-title>
<source/>Indian Pediatr
          <year>2012</year>
<volume>49</volume>
<fpage>659</fpage>
<lpage>661</lpage>
<pub-id pub-id-type="doi">10.1007/s13312-012-0129-y</pub-id>
<pub-id pub-id-type="pmid">22962239</pub-id>
</element-citation>
</ref>
<ref id="CR94">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marchand</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Using probiotics in the paediatric population</article-title>
<source/>Paediatr Child Health
          <year>2012</year>
<volume>17</volume>
<fpage>575</fpage>
<lpage>576</lpage>
<pub-id pub-id-type="doi">10.1093/pch/17.10.575</pub-id>
<pub-id pub-id-type="pmid">24294069</pub-id>
</element-citation>
</ref>
<ref id="CR95">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Versalovic</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>The human microbiome and probiotics: implications for pediatrics</article-title>
<source/>Ann Nutr Metab
          <year>2013</year>
<volume>63</volume>
<issue>Suppl 2</issue>
<fpage>42</fpage>
<lpage>52</lpage>
<pub-id pub-id-type="doi">10.1159/000354899</pub-id>
</element-citation>
</ref>
<ref id="CR96">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bested</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Logan</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Selhub</surname>
<given-names>EM</given-names>
</name>
</person-group>
<article-title>Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: part III—convergence toward clinical trials</article-title>
<source/>Gut Pathog
          <year>2013</year>
<volume>16</volume>
<fpage>4</fpage>
<pub-id pub-id-type="doi">10.1186/1757-4749-5-4</pub-id>
</element-citation>
</ref>
<ref id="CR97">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davari</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Talaei</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Alaei</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Salami</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Probiotics treatment improves diabetes-induced impairment of synaptic activity and cognitive function: behavioral and electrophysiological proofs for microbiome-gut-brain axis</article-title>
<source/>Neuroscience
          <year>2013</year>
<volume>14</volume>
<fpage>287</fpage>
<lpage>296</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2013.02.055</pub-id>
</element-citation>
</ref>
<ref id="CR98">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akombi</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Agho</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Merom</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Renzaho</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Hall</surname>
<given-names>JJ</given-names>
</name>
</person-group>
<article-title>Child malnutrition in sub-Saharan Africa: a meta-analysis of demographic and health surveys (2006-2016)</article-title>
<source/>PLoS One
          <year>2017</year>
<volume>12</volume>
<fpage>e0177338</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0177338</pub-id>
<pub-id pub-id-type="pmid">28494007</pub-id>
</element-citation>
</ref>
<ref id="CR99">
<label>99.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wuehler</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Biga Hassoumi</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Situational analysis of infant and young child nutrition policies and programmatic activities in Niger</article-title>
<source/>Matern Child Nutr
          <year>2011</year>
<volume>7</volume>
<fpage>133</fpage>
<lpage>156</lpage>
<pub-id pub-id-type="doi">10.1111/j.1740-8709.2010.00307.x</pub-id>
<pub-id pub-id-type="pmid">21410893</pub-id>
</element-citation>
</ref>
<ref id="CR100">
<label>100.</label>
<mixed-citation publication-type="other">Kouassi F. Study on the underlying causes for under-nutrition, Department of Mayahi, Region of Maradi, November 2016 to March 2017. Link Unit NCA, Action Against Hunger, May 2017. <ext-link ext-link-type="uri" xlink:href="http://linknca.org/communaute.htm?lng=en">http://linknca.org/communaute.htm?lng=en</ext-link>.</mixed-citation>
</ref>
<ref id="CR101">
<label>101.</label>
<mixed-citation publication-type="other">Anonymous. Evaluation de la situation nutritionnelle par la méthodologie SMART au Niger. Institut National de la Statistique. Rapport final, novembre 2016.</mixed-citation>
</ref>
<ref id="CR102">
<label>102.</label>
<mixed-citation publication-type="other">Anonymous. Enquête Démographique et de Santé à Indicateurs Multiples 2010-2011. Agence Nationale de la Statistique et de la Démographie du Sénégal. Ministère de la Santé Publique, Dakar 2012.</mixed-citation>
</ref>
<ref id="CR103">
<label>103.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caleo</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Sy</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Balandine</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Polonsky</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Palma</surname>
<given-names>PP</given-names>
</name>
<name>
<surname>Grais</surname>
<given-names>RF</given-names>
</name>
<name>
<surname>Checchi</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Sentinel site community surveillance of mortality and nutritional status in southwestern Central African Republic, 2010</article-title>
<source/>Popul Health Metr
          <year>2012</year>
<volume>10</volume>
<fpage>18</fpage>
<pub-id pub-id-type="doi">10.1186/1478-7954-10-18</pub-id>
<pub-id pub-id-type="pmid">22947146</pub-id>
</element-citation>
</ref>
<ref id="CR104">
<label>104.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Breurec</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Vanel</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Bata</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Chartier</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Farra</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Favennec</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Vray</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Etiology and epidemiology of diarrhea in hospitalized children from low income country: a matched case-control study in Central African Republic</article-title>
<source/>PLoS Negl Trop Dis
          <year>2016</year>
<volume>10</volume>
<fpage>e0004283</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pntd.0004283</pub-id>
<pub-id pub-id-type="pmid">26731629</pub-id>
</element-citation>
</ref>
<ref id="CR105">
<label>105.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Enenkel</surname>
<given-names>M</given-names>
</name>
<name>
<surname>See</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Karner</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Alvarez</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rogenhofer</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Baraldes-Vallverdu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lanusse</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Salse</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Food security monitoring via mobile data collection and remote sensing: results from the Central African Republic</article-title>
<source/>PLoS One
          <year>2015</year>
<volume>10</volume>
<fpage>e0142030</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0142030</pub-id>
<pub-id pub-id-type="pmid">26581042</pub-id>
</element-citation>
</ref>
<ref id="CR106">
<label>106.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wakabi</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>Health crisis worsens in Central African Republic</article-title>
<source/>Lancet
          <year>2006</year>
<volume>367</volume>
<fpage>1969</fpage>
<lpage>1970</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(06)68865-X</pub-id>
<pub-id pub-id-type="pmid">16786605</pub-id>
</element-citation>
</ref>
<ref id="CR107">
<label>107.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Golden</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Proposed recommended nutrient densities for moderately malnourished children</article-title>
<source/>Food Nutr Bull
          <year>2009</year>
<volume>30</volume>
<fpage>S267</fpage>
<lpage>S342</lpage>
<pub-id pub-id-type="doi">10.1177/15648265090303S302</pub-id>
<pub-id pub-id-type="pmid">19998863</pub-id>
</element-citation>
</ref>
<ref id="CR108">
<label>108.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilson</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Whelan</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Prebiotic inulin-type fructans and galacto-oligosaccharides: definition, specificity, function, and application in gastrointestinal disorders</article-title>
<source/>J Gastroenterol Hepatol
          <year>2017</year>
<volume>32</volume>
<fpage>64</fpage>
<lpage>68</lpage>
<pub-id pub-id-type="doi">10.1111/jgh.13700</pub-id>
</element-citation>
</ref>
<ref id="CR109">
<label>109.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Healey</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Butts</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Brough</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Whelan</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Coad</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Habitual dietary fibre intake influences gut microbiota response to an inulin-type fructan prebiotic: a randomised, double-blind, placebo-controlled, cross-over, human intervention study</article-title>
<source/>Br J Nutr
          <year>2018</year>
<volume>119</volume>
<fpage>176</fpage>
<lpage>189</lpage>
<pub-id pub-id-type="doi">10.1017/S0007114517003440</pub-id>
<pub-id pub-id-type="pmid">29307330</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>